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I saw the best minds of my generation destroyed by madness, 
starving hysterical naked, 
dragging themselves through the negro streets at dawn looking for 
an angry fix, 
angelheaded hipsters burning for the ancient heavenly connection 
to the starry dynamo in the machinery of night 
All you, who know desire in these seas, 
Have souls or equipment for loneliness, loneliness 
Lean now like fruitage. The Hesperides 
Open, This is the limbo, the doldrum, 
Seal down the eye of your cyclops, 
Silence Time's drum. 
Drink up, dreamers, you're running dry. 
Allen Ginsberg 
Lawrence Durrell 
Peter Gabriel 
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ABSTRACT 
Southwestern blotting identified two major proteins in heparin-agarose purified endometrial nuclear 
extract that bind to the -194/+9 region of the rabbit uteroglobin promoter, pI 05 and p70. These 
proteins were presented as candidate components of the uteroglobin promotor binding complex 
(UGPB), a protein complex proposed to regulate expression of the endometrial uteroglobin gene. 
Both p 105 and p70 displayed similar binding characteristics as UGPB and p 105 was established to 
co-purify with UGPB during affinity purification. Inclusion of competing DNA in Southwestern 
blotting suggested that p105 is a relatively non-specific DNA binding protein, whereas p70 is more 
specific. Both pI 05 and p70 were shown to bind to the UGPB DNase I footprint region of the 
uteroglobin promoter (-170/-85) and it was suggested that p105 may bind distally to the uteroglobin 
transcription start site, while p70 binds proximally. p105 and p70 were identified in unstimulated 
endometrial extracts as well as endometrial extracts from progesterone and oestrogen stimulated 
rabbits. pl05 may also be present in unstimulated and oestrogen-dominated lung extracts and in 
oestrogen-dominated ovary extracts. Several minor proteins were identified in heparin-agarose 
purified endometrium that may also playa role in the UGPB complex. 
KEYWORDS: uteroglobin, promoter, transcription factor, Southwestern blotting, gel shift assay, 
uteroglobin promoter binding factor (UGPB), p105, p70, competition, binding site. 
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CHAPTER 1 - LITERATURE REVIEW. 
1.1. Introduction - the Problem of Eukaryotic Gene Regulation. 
In a eukaryotic organism, many genes are expressed in a temporal or tissue-specific 
manner, and their expression is often regulated by extracellular factors such as hormones. 
Establishing how the expression of such genes is regulated has become a central question 
in molecular biology. Two basic types of control factors are involved: cis-acting DNA 
elements and trans-acting factors that bind to these elements. Cis-acting elements 
(promoters and enhancers) are identified by mutating cloned genes to identify which 
regions are crucial for expression. Promoters are located immediately upstream of the 
transcription start site and include all the sequences required for accurate and efficient 
transcription (Maniatis, Goodbourn & Fischer 1987). Eukaryotic promoters classically 
include an AT rich region (the TAT A or Goldberg-Rogness box) in the -20 to -30 region 
and may include other upstream promoter elements (UPE's) such as a CCAAT box or GC 
rich region (Atchison 1988). Enhancers also contain conserved DNA sequences, but can 
regulate genes many kilobases away and can operate regardless of their orientation 
(Atchison 1988). Enhancers can have a positive or negative effect on transcription. 
Sequences within the promoter and enhancer are recognised by trans-acting factors. 
Binding of these trans-acting factors (or transcription factors) may stimulate or inhibit the 
formation and activity of the pre-initiation complex, that contains RNA polymerase along 
with several universal transcription factors such as TFIID. Many transcription factors 
bind to sites quite distant from the transcription start site and there are several theories as 
to how such distant factors can affect the formation or activity of the pre-initiation 
complex. Four major theories are proposed: looping, sliding, twisting and oozing 
(Ptashne 1986). 
1) Looping - The transcription factor and pre-initiation complex interact directly, with the 
intervening DNA bending or looping to allow interaction. 
2) Sliding - The transcription factor moves along the DNA from its recognition site to 
the transcription start site. 
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3) Twisting - Binding of the transcription factor to its recognition site alters DNA 
confonnation, which is propagated through the DNA double helix to the start site where it 
facilitates or inhibits binding of the pre-initiation complex. 
4) Ooozing - Binding of a transcription factor helps binding of an adjacent factor, until a 
series of proteins has "oozed" from the transcription factor recognition site to the 
transcription start site. 
Most evidence now favours the looping model, although recent investigations suggest 
that activation of at least one viral gene involves sliding of a transcription factor along 
DNA (Herendeen, Kassavetis & Geiduschek 1992). 
Many transcription factors have now been identified by gel shift assay, DNase I 
footprinting, cloning or purification. Elucidation of the structure of some transcription 
factors by X-ray crystallography has suggested the DNA binding motifs of transcription 
factors fall into three major classes: helix-turn-helix, zinc fmgers and leucine zippers. All 
of these classes of DNA binding motif appear to recognise specific DNA sequences by 
hydrogen bonding and other stereo-specific molecular interactions between amino acid 
residues of the transcription factor and the nucleotide bases in the major groove of the 
DNA double helix. Of particular interest in the induction of gene transcription by 
extracellular signals are the nuclear receptor proteins, a group of zinc finger transcription 
factors whose activity is regulated by honnone binding and which bind to honnone 
response elements (HRE's) in DNA. Nuclear receptor proteins include receptors for a 
wide range of mammalian honnones such as progesterone, oestrogen and glucocorticoids 
and appear to have evolved from a single ancestral transcription factor (Amero et. al. 
1992). 
The regulation of transcription is of course much more complex than this brief overview 
suggests Important questions such as the role of histone proteins in preventing association 
of transcription factors with DNA and how transcription factors are themselves regulated 
at the transcriptional and post-translational level are still unanswered (Felsenfeld 1992; 
Green 1992; Ptashne & Gann 1990). Yet the fundamental question of eukaryotic gene 
regulation remains thye means by which proteins binding to specific sequences interact 
with each other and the pre-initiation complex to regulate gene expression in response to 
extracellular signals. 
This dissertation details the characterisation of a putative transcription factor complex 
binding to the promoter of the rabbit uteroglobin gene, a gene that is expressed in the 
endometrium in response to progesterone and oestrogen. 
1.2. Uteroglobin - Structure, Function and Regulation. 
1.2.1. Uteroglobin Structure and Function. 
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Uteroglobin (or blastokinin) was fIrst isolated as a major component of rabbit uterine 
flushings that appears just before blastulation, increases in concentration until 
approximately 5 days post coitus (p.c.) and declines to near zero by 9 days p.c. (Krishnan 
& Daniel 1967). A partially purifIed fraction of uteroglobin affected embryo development 
in vitro, so it was proposed to be an endogenous regulator of blastocyst development 
(Krishnan & Daniel 1967). Uteroglobin exists primarily in the endometrium of pregnant 
rabbits in vivo and its secretion can be stimulated by progesterone and oestradiol (Beier 
1968). Although the function of uteroglobin is still disputed, the link between uteroglobin 
expression and reproductive hormones has fuelled widespread research and uteroglobin 
has been used as a model for the control of gene expression by steroid hormones. 
U teroglobin is a low molecular weight protein, with a theoretical molecular weight of 15 
800. Uteroglobin exists as a dimer consisting of two identical 70 amino acid chains linked 
in an antiparallel structure by two disulphide bonds (see Figure 1). There are no reports of 
the isolation of free uteroglobin subunits in vivo (Miele, CordelIa-Miele & MukheIjee 
1990). Reduction of disulphide bonds does not result in dissociation of the dimer, 
indicating that van der Waals interactions, hydrogen bonds and other stereo-specifIc 
interactions are important in stabilising the dimer. Several crystalline forms of 
uteroglobin have been obtained, suggesting it may have a large degree of conformational 
mobility. 
Figure 1. Projection of the uteroglobin dimer with only a carbons shown. (Miele, 
Cordella-Mie1e & Mukherjee 1987, p475). 
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In addition to the uterus, uteroglobin has been found in the oviduct, tracheobronchial tree 
(where it is also tenned Clara cell secretory protein or CCSP), digestive tract and male 
genital tract of the rabbit (Lopez de Haro, Alvarez & Nieto 1988; Miele, CordelIa-Miele 
& Mukherjee 1987). Uteroglobin is secreted by specific epithelial cells within these 
organs; in situ hybridization using uteroglobin cDNA has identified uteroglobin 
transcription in the uterine endometrial epithelium (particularly the glandular epithelium) 
and in ciliated and bronchiolar cells of the bronchi and bronchiolar epithelium 
(Warembourg et. al. 1986). 
Uteroglobin homologues have been isolated in several other species. A uteroglobin-like 
protein was first detected in tracheobronchial washings of human neonates (Dhanireddy, 
Kikukawa & Mukherjee 1988). This protein, CClO (Clara cell 10 kDa protein), has also 
been identified in rats and is secreted from Clara cells in the surface epithelium of the 
pulmonary airways. Both rat and human CClO have a similar structure and gene sequence 
to rabbit uteroglobin (Singh et. al. 1990). A uteroglobin homologue can be detected by 
RIA and Western blotting procedures specific for rabbit uteroglobin in the human 
endometrium and human prostate (Kikukawa et. al. 1988; Manyak, Kikukawa & 
Mukherjee 1988). A mouse uteroglobin homologue is expressed in the lung, but is not 
detected in the reproductive tract. Introduction of the rabbit uteroglobin gene into the 
mouse genome results in expression primarily in the lung (DeMayo et. al. 1991). 
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The function of uteroglobin is still disputed. Uteroglobin is able to bind progesterone and 
related compounds (certain methyl-sulfonyl-PCB 's), probably in a symmetric binding site 
between the two subunits. Disulphide bonds linking the two subunits must be cleaved for 
progesterone binding to occur and this is thought to be necessary for progesterone entry, 
as the cystine residues have been shown to take no part in the binding process (Gillner et. 
a!. 1988; Miele, Cordella-Miele & MukheIjee 1987). Whether the progesterone-binding 
ability of uteroglobin has any physiological significance is unknown, but it has been used 
as the basis of proposals that uteroglobin is a carrier of progesterone between the uterus 
and blastocyst, a progesterone scavenger or a factor involved in maintaining high levels 
of progesterone in the pre-implantation uterus (Miele, Cordella-Miele & Mukherjee 
1987). 
Alternatively, it has been suggested that uteroglobin has a role in masking the 
antigenicity of embryos and therefore inhibits their rejection by the maternal immune 
system. Uteroglobin has been shown to reduce maternal lymphocyte proliferation in 
response to inactivated blastomeres in vitro, as measured by H3-thymidine incorporation 
by the lymphocytes (MukheIjee, Ulane & Agrawal 1982). Incubation with anti-
uteroglobin eliminated the suppression of lymphocyte proliferation. MukheIjee, Ulane & 
Agrawal (1982) inferred from these results that uteroglobin becomes covalently cross-
linked to embryonic cell surface antigens and prevents recognition by the maternal 
immune system. 
However, this theory applies specifically to rabbit endometrial uteroglobin and does not 
explain the presence of uteroglobin in other tissues. Recent evidence suggests that 
uteroglobin may have an anti-inflammatory role, triggered by observations that 
uteroglobin can inhibit monocyte and neutrophil chemotaxis and phagocytosis in vitro 
and inhibit thrombin-induced platelet aggregation. Furthermore, purified uteroglobin 
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inhibits phospholipase A2 (PLA2) activity, an enzyme that releases arachidonic"acid from 
cell membranes, the major source of the arachidonic acid derivatives (prostaglandins, 
thromboxanes and leukotrienes) that regulate the inflammatory response (Miele, 
CordelIa-Miele & Mukherjee 1987). Uteroglobin has a similar three-dimensional 
structure to PLA2 and it has been proposed that the progesterone binding site may 
actually bind membrane phospholipids in vivo and therefore inhibit PLA2 by preventing 
PLA2-substrate interaction (Singh et. al. 1990). 
In 1988, a nonapeptide (MQMKKVLDS) corresponding to regions of highest similarity 
between utero globin and lipocortin I (an in vitro inhibitor of phospholipase A2) was 
shown to be a inhibitor of PLA2 in vitro and to have a potent anti-inflammatory effect on 
rat footpad oedema (Miele et. al. 1988). However, these results are disputed, as several 
other groups have not been able to reproduce either the in vitro PLA2 inhibition or in 
vivo anti-inflammatory action of this peptide under the same conditions (Marki et. al. 
1990; Singh et. al. 1990). Yet the anti-inflammatory role for uteroglobin remains the most 
persuasive. The attraction of this theory is that it presents an explanation for the presence 
of uteroglobin in a variety of tissues, in preventing overt thrombosis and inflammation. In 
the uterus, progesterone induced secretion of uteroglobin could playa role in the 
suppression of local inflammatory and immune responses against the pre-implantation 
embryo. (Miele, CordelIa-Miele & Mukherjee 1987). 
1.2.2. Hormonal Control of Uteroglobin Expression. 
Regardless of its function, uteroglobin is an important model of steroid hormone gene 
regulation. The hormone regulation of uteroglobin levels is relatively complex. As 
mentioned above, Beier (1968) demonstrated that rabbit uterine uteroglobin levels can be 
stimulated in pregnant rabbits by concomitant treatment with progesterone and oestradiol. 
Uteroglobin can be stimulated by progesterone alone in ovariectomised and intact 
oestrous rabbits (Arthur & Daniel 1972). The kinetics and appearance of uteroglobin in 
uterine fluid is similar during progesterone treatment and normal pregnancy, but there are 
still significant levels of uteroglobin present after 15 days of progesterone administration 
(>10% uterine fluid). In the normal pregnant female however, uteroglobin appears at day 
2, peaks at day 5 and disappears at day 10, suggesting factors other than progesterone are 
also regulating uteroglobin levels in vivo. 
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Bullock & Willen (1974) demonstrated that superimposition of oestradiol during a 
progesterone regime significantly reduced the proportion of uteroglobin in uterine fluid. 
This study indicated oestradiol suppresses progesterone-induced uteroglobin synthesis, 
which is consistent with the pattern of steroid hormone secretion during early pregnancy. 
Yet it has been suggested that oestradiol alone can induce uteroglobin in the oviduct and 
uterus, although this is disputed (Goswami & Feigelson 1974). Sequential treatment with 
progesterone and low doses of oestradiol cause the highest rates of uteroglobin synthesis, 
whereas high doses of oestradiol inhibit progesterone stimulation (Miele, CordelIa-Miele 
& Mukherjee 1987). The interplay of progesterone and oestradiol in the regulation of 
uteroglobin synthesis is therefore relatively complex and may be dependent on the 
developmental status of the animal (Miele, CordelIa-Miele & Mukherjee 1987). Prolactin 
may also playa role in the control of uteroglobin production and may interact with 
progesterone in a servomechanism, whereby prolactin and progesterone stimulate levels 
of the progesterone and prolactin receptors respectively. (Daniel & Juneja 1989; Chilton, 
Mani & Bullock 1988). 
The effect of these hormones on uteroglobin levels need not necessarily imply direct 
regulation of uteroglobin gene expression by steroid hormones. Progesterone causes a 
rapid increase in transcriptional activity per endometrial cell, leading to the differentiation 
of luminal cells into glandular epithelium. These general mitogenic effects are important 
in the early increase in uteroglobin levels (Shen et. al. 1983). Progesterone and oestrogen 
together are antagonistic and do not induce uterine proliferation, closely corresponding to 
their behaviour in controlling uteroglobin levels. Secondly, RNA processing and overall 
transcriptional activity may be regulated by these hormones. Progesterone also appears to 
affect the translation and secretion of uteroglobin and oestrogen affects uteroglobin 
translation (Miele, CordelIa-Miele & Mukherjee 1987). Finally, Oestrogen and 
progesterone can also regulate the level of progesterone receptor (PR) with oestrogen 
generally up-regulating PR levels and prolonged progesterone treatment down-regulating 
PR levels (Miele, CordelIa-Miele & Mukherjee 1987). 
However during pregnancy, changes in uteroglobin mRNA activity is the major source of 
the increase in endometrial uteroglobin levels (Kao & Bullock 1981). Several studies 
have demonstrated that progesterone stimulates endometrial uteroglobin transcription 
(Kumar et. al. 1982). Long tenn progesterone treatment decreases endometrial 
uteroglobin mRNA transcription, suggesting this may have some role in the decline in 
uteroglobin production during pregnancy (Shen et. al. 1983). Whether oestrogen alone 
can also stimulate endometrial uteroglobin expression is disputed (Shen et. al. 1983; 
Miele, Cordella-Miele & Mukherjee 1987). 
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Honnonal control of uteroglobin is very different in other tissues. Transcription of CCSP 
(the uteroglobin homologue in the rabbit lung) is regulated by glucocorticoids at both the 
transcriptional and post-transcriptional level and is unaffected by pregnancy (Bullock 
1977; Miele, Cordella-Miele & Mukherjee 1987). Rat CClO (the uteroglobin homologue 
in the lung), is also regulated by glucocorticoids (Hagen et. al. 1990). Both the 
endogenous mouse uteroglobin homologue and an introduced rabbit uteroglobin gene are 
regulated by glucocorticoids in the mouse lung (DeMayo et. al. 1991). Androgens may 
directly regulate uteroglobin expression in the male genital tract. In particular, 
testosterone increases uteroglobin levels and uteroglobin mRNA synthesis in the rabbit 
epididymis, but not the testis (Lopez de Haro, Alvarez & Nieto 1988). 
1.2.3. The Uteroglobin Gene. 
For a meaningful discussion of the regulation of utero globin gene expression, a brief 
outline of the uteroglobin gene structure is needed. Several groups have isolated genomic 
clones of the rabbit uteroglobin gene, which is about 3kb long, with 3 exons (l03bp, 
188bp and 174bp long respectively) and 2 introns (2270bp and 332bp long), as shown in 
Figure 2 (Snead et. al. 1981). As it is a secretory protein, utero globin mRNA is 
synthesised as a precursor (pre-uteroglobin) with a signal peptide 21 amino acids long at 
the amino tenninus. Pre-uteroglobin also includes a 142 nucleotide (nt) 3' nontranslated 
region, including a polyadenylation signal. The poly(A) tail length is 40-120nt long 
(Miele, Cordell a-Miele & Mukherjee 1987). There appears to be only one major pre-
uteroglobin mRNA product, although two large uteroglobin mRNA molecules have been 
identified as incompletely spliced precursors (Snead et. al. 1981). Several possible minor 
transcription start sites have been identified at -69, -71 and +81 (Bailly et. al. 1983). 
[AUG) 
(9) (74) 
BamH I BstE II 
[UAG) 
(119) (246) (331) (462) 
Ava I Hint I Hint I Sau3A 
1 1~ ~--------~--------~~ 
----r-1 n-ss tE----1I -------;-,--A~t~ tt B1 -'--t ----r--:---
1 BamH , Hht ,1 '-r-' Pvu II EcoR , EcoR , 
Xba I 8g1 II EcoR 1 Pst I Cia I 
o 1.0 2.0 3.0 4.0 5.0 
Kb 
Figure 2. Molecular structure of the uteroglobin gene. (Snead et. al., 1981, p11915). 
(Shaded box: exons; Open box: introns; - : flanking sequences) 
Uteroglobin has been used as a model for the regulation of gene expression by steroid 
hormones, as described above. The structure of the uteroglobin promoter is particularly 
relevant as steroid hormone receptors are thought to bind to hormone response elements 
(HRE's) upstream of a steroid regulated gene. The uteroglobin promoter contains an 
atypical Goldberg-Hogness box (GAATACAAAA) at -34 to -24, as well as two other 
Arr rich regions (Bailly et. al. 1983). 
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Most importantly, several hormone receptor binding sites have been identified. 
Progesterone response elements (PRE's) have been identified upstream (-2946/-2605 and 
-2568/-1842) and within the first intron (+ 197/+ 1054). Glucocorticoid response elements 
have been identified about 2.6kb upstream from the start site and there is a suggestion 
that progesterone receptor may bind to these sites (Miele, CordelIa-Miele & Mukherjee 
1987). Two oestrogen response elements (ERE) have also been identified, one of which 
overlaps with the glucocorticoid response site, while the other is located at -266/-252. 
The -262/-252 ERE is an imperfect palindrome differing by only one nucleotide from the 
consensus for this response element (Lopez de Haro, Garcia & Nieto 1990). 
The rat CC10 uteroglobin homologue, which is regulated by glucocorticoids, lacks two 
major 5' regions of 0.9kb and 2.1kb, including the progesterone response element, 
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glucocorticoid response element and overlapping oestrogen response element, as well as 
the oestrogen response element at -266/-252. No regulatory element for ovarian hormones 
has been found in the rat CClO gene, but three potential glucocorticoid binding sites exist 
in the 5' region (Hagen et. al. 1990). 
1.2.4. Regulation of Uteroglobin at the Molecular Level - Hormone Receptors and 
UGPB. 
Rabbit endometrial uteroglobin levels have been widely studied as a model for hormonal 
regulation of genes. What then are the molecular details of uteroglobin regulation by 
hormones? In general, in vivo binding of hormones to their receptor is thought to induce 
conformational changes that allow the receptor to interact with its DNA target sequence. 
The movement of the receptor from the cytoplasm into the nucleus can also be hormone-
dependent. DNase I footprinting revealed that the progesterone receptor interacts with 
high affinity to the PRE sites in the uteroglobin promoter described above, with two 
footprints in the -2427/-2376 region, three footprints in the -2709/-2620 region and two 
lower affinity footprints within the first intron (Bailly et. al. 1986). Experiments initially 
indicated binding of progesterone receptor to the -394/+ 10 region, but this result was 
unrepeatable and is now thought to be an artifact due to co-purification of a promoter 
binding factor (Bailly et. al. 1983; Miele, Cordella-Miele & MukheIjee 1987). 
Progesterone receptor binding to the two upstream regions has been confmned by 
electron microscopy, which showed receptors bound at the two distinct sites interacting 
and looping out of the intervening DNA between the sites (Theveny et. al. 1987). 
Three glucocorticoid binding sites have been demonstrated in the -2711/-2621 region and 
as progesterone and glucocorticoid receptors recognise the same motif, these sites may 
also be bound by progesterone receptors. DNase I footprinting also established that the 
oestrogen receptor binds to the partial ERE, giving a footprint between -269 and -244 
(Slater et. al. 1989). Chloramphenicol acetyl transferase (CAT) assays in the Ishikawa 
cell line (an endometrial tumour line) show that this ERE is necessary for oestrogen 
induction of the uteroglobin promoter. 
It has therefore been well established that steroid receptors can interact with the response 
elements in the 5' region of the uteroglobin gene. Whether these hormone response 
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elements play an active role in regulating uteroglobin expression in vivo is a different 
question. Four DNase I hypersensitive sites have been detected in the uteroglobin gene, 
three of which, at -100, -2400 and -3700, are only found in progesterone-oestrogen 
treated endometrium (Jantzen et. al. 1987). Of the three, oestrogen alone could induce the 
-100 and -3700 sites and glucocorticoids could not induce any. DNase I hypersensitivity 
has been identified in many expressed genes and is thought to represent an open DNA 
conformation at that site. In this case, DNase I hypersensitivity may be the result of 
receptor binding, or may indicate a region of DNA which is intrinsically more accessible 
for protein binding. This is the best evidence that the hormone response elements are 
involved in uteroglobin regulation, although no DNase I hypersensitivity was observed at 
the -2711 to -2621 region, known to contain PRE's. 
The hormone response elements are all relatively distal to the promoter that they are 
thought to influence. As discussed above, transcription factors probably act at a distance 
by interacting directly with other factors near the transcription start site accompanied by 
looping out of the intervening DNA, although there is now evidence that some at least 
slide along the DNA. In the utero globin gene, the observations of Theveny et. al. (1987) 
that progesterone receptors bound to the two upstream regions can interact has prompted 
suggestions that this receptor-receptor complex (R) may act by enhancing binding of 
transcription factors (TF) to the promoter region (P) (see Figure 3). 
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Figure 3. Possible function of the interaction of DNA bound progesterone receptors 
in the regUlation of uteroglobin transcription. (Theveny et. aI. 1987, p80). 
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In recent years several research groups have identified putative transcription factors that 
may regulate the uteroglobin gene and interact with nuclear receptors binding to distal 
elements. Misseyani et. al. (1991) investigated the ability of the utero globin promoter to 
allow transcription of a reporter gene in two human cell lines, Ishikawa (human 
endometrial tumour cells) and HeLa cells (human cervical carcinoma cells). They 
identified three regions, -258/-220, -205/-177 and -96/-35 as important for preferential 
transcription in endometrial cells and established 7 DNase I footprints in Ishikawa cells in 
these regions, although only two footprints in the TATA box region (-40/-23) were 
specific to Ishikawa cells. A trans-acting factor binding specifically to the -40/-23 region 
was identified by gel shift assay. Gel shift assays detect proteins that slow the passage of 
a labelled piece of DNA through a polyacrylamide gel and specificity is determined by 
competition with excess unlabelled probe. The universal transcription factor TFIID is 
usually assumed to bind to the TAT A box, but Misseyani et. al. (1991) suggest the trans-
acting factor they identified may be an endometrium-specific TATA-box binding factor. 
In 1988, Rider & Bullock detected a trans-acting factor by gel shift assay in a crude 
progesterone-dominated endometrial nuclear extract that bound to the -194/+9 (UG200) 
region. The promoter binding activity was found in progesterone-dominated 
endometrium, but not in lung, liver or unstimulated endometrium. Levels of the promoter 
binding factor increased with progesterone stimulation in parallel to uteroglobin mRNA 
levels. This promoter binding factor (Utero globin Promoter Binding Factor or UGPB) 
binds to a region within the -100 DNase I hypersensitivity region reported by Bailly et. al. 
(1987) and is probably not the progesterone receptor, as evidence suggests the 
progesterone receptor does not bind to this region. UGPB was therefore hypothesised to 
be a transcription factor involved in the regulation of utero globin transcription and which 
may interact with progesterone receptors bound to the upstream PRE's. 
Rider & Peterson (1991) established UGPB was able to bind the -194/-68 region 
(UG126) and observed two DNase I footprints in this region, at -160/-144 and -142/-120, 
with DNase I hypersensitive sites at -112 and -105. This binding site differentiates UGPB 
from the putative endometrium-specific TATA-box binding factor identified by 
Misseyani et. al. (1991), which binds to the -40/-23 region. Southwestern blotting and UV 
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cross linking revealed two proteins (MW 95000 and 115 000) that bound the UG126 
fragment and were found in crude progesterone-dominated endometrium but not kidney 
and lung. Other smaller proteins were also observed to bind UG 126, but these were not 
always present and were not specific to progesterone-dominated endometrium. Rider & 
Peterson (1991) proposed that binding of these two proteins accounts for the -100 DNase 
I hypersensitive region discussed previously. Furthermore they suggest that the two 
promoter-binding proteins make up UGPB and activate uteroglobin expression. 
The primary question remaining is whether UGPB is, as Rider & Peterson (1991) assert, 
a endometrial-specific modulator of uteroglobin gene expression. There is still no direct 
evidence that UGPB has a functional role in regulating uteroglobin expression. The 
evidence Rider & Peterson (1991) use is threefold: analogy to other hormone-regulated 
genes, the presence of a hypersensisitve site in the region and the increase in apparent 
UGPB levels correlating with increased uteroglobin levels. However, the DNase I 
hypersensitive site could be the result of proteins such as RNA polymerase or matrix 
attachment proteins binding and research into whether the presence of UGPB during 
pregnancy correlates with uteroglobin expression would be informative. To clarify the 
role of UGPB in regulating uteroglobin gene expression, UGPB needs to be purified and 
used in an in vitro transcription system. 
A related question is the composition and behaviour of UGPE. Although the Rider & 
Peterson (1991) paper advances knowledge of UGPB, some of the results run contrary to 
work undertaken at Lincoln University. DNase I footprinting detected a similar region of 
protection to that published by Rider and Peterson (1991), but it was interpreted as a 
single footprint over the -167/-85 region on the coding strand and -170/-81 on the non-
coding strand, with no region of DNase I hypersensitivity (c. Molloy, personal 
communication). Furthermore, the binding site of UGPB has been narrowed down using 
oligonucleotides spanning all or part of the footprint region, which showed binding 
efficiencies in the folllowing order: -170/-85 > -170/-100 > -154/-100 > -170/-118. 
Smaller fragments (-154/-118 and -117/-85) showed negligible binding activity (C. 
Molloy, personal communication). Finally, the Southwestern blotting procedure used by 
Rider & Peterson (1991) involved binding of nuclear proteins to UG126 at lOmM MgCl2 
and washing at 300mM NaCI and lOmM MgCI2, conditions known to have significantly 
increase the rate of dissociation of the UaPB complex (P. Daniel, personal 
communication). This observation led to attempts to repeat the Southwestern blotting 
results reported by Rider & Peterson (1991) and the results of these and other 
experiments form the basis of this dissertation. 
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1.3. Southwestern Blotting - A Technique to Detect DNA-Binding Proteins. 
Southwestern blotting is a technique devised by Miskimmins et. al. (1985) to identify 
nuclear proteins that recognise specific DNA sequences. Essentially, it involves six steps: 
1) Separating nuclear proteins by discontinuous polyacrylamide gel electrophoresis, by 
the method of Laemmli (1970). 
2) Transferring proteins by transverse electrophoresis from the polyacrylamide gel to 
nitrocellulose, or similar protein-binding membrane. 
3) Blocking unbound sites on the membrane by incubation of the membrane in blocking 
buffer, containing a protein such as BSA, or more commonly non fat dried milk (Bovine 
Lacto Transfer Technique Optimizer or BLOTTO). 
4) Incubating membrane with the 32P-Iabelled DNA fragment of interest. 
5) Washing membrane to remove unbound probe. 
6) Exposing membrane to X-ray film. 
Since its inception, Southwestern blotting has been used widely in the study of DNA-
binding proteins. It is most often used to determine the molecular weight of DNA-binding 
proteins identified by gel shift assay, such as a 60 kDa polypeptide binding to the rat neu 
oncogene promoter (Yan & Hung 1991). Other more specialised approaches include 
using Southwestern blotting to monitor the purification of DNA-binding proteins, or to 
identify the sequence recognised by DNA-binding proteins by screening a membrane 
with a variety of probes (Well stein et. al. 1991; Keller & Maniatis 1991). 
However, there are some problems with this approach to identify DNA-binding proteins. 
Firstly, the gel and transfer conditions will denature much of the protein and eliminate 
much DNA binding activity. As a result, much more protein needs to be used in 
Southwestern blots than in other techniques to identify DNA-binding proteins, such as gel 
shift assays. Nuclear proteins are not boiled before loading on to the polyacrylamide gel 
to avoid complete denaturation and are instead incubated at room temperature in a sample 
buffer containing 5% SDS. Denaturation can be overcome to some extent by complete 
denaturation of proteins bound to the membrane in guanidine-Hel after blocking, then 
allowing 24 hours for the proteins to renature spontaneously (Staudt et. al. 1988). 
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Secondly, it is important to know whether the proteins detected are binding specifically to 
the probe, or are non-specific DNA-binding proteins such as histones. Several approaches 
can be used to determine ~pecificity, although it should be noted that many researchers do 
not attempt to establish it. Probes of different sequence can be used to determine the 
range of DNA sequence that will be bound (yan & Hung 1991). Alternatively, unlabelled 
competitor DNA can be used, as is common in gel shift assays. Inclusion of excess 
unlabelled probe sequence should decrease the amount of labelled probe bound by 
specific DNA-binding proteins and so diminish the intensity of the band identified by 
autoradiography. Non-specific DNA-binding proteins are thought to be present in much 
higher quantities, so they will still bind large amounts of labelled probe in the presence of 
excess unlabelled probe (Reifel-Miller, Berg & Grinnell 1991). 
The most significant problem with Southwestern blotting is that there is no necessary link 
between proteins identified by this technique and proteins identified by other techniques 
such as gel shift assays and DNase I footprinting. In fact the binding conditions are very 
different, as in Southwestern blotting the proteins are separated and immobilised on a 
membrane rather than free in solution. There are two conceptual approaches to link the 
proteins identified by gel shift assay and Southwestern blots. Indirect methods show that 
the two proteins behave in the same way; for example they are present in the same tissue 
samples, bind to the same DNA sequences, are co-purified and so on. Many researchers 
use different tissue samples to establish that proteins identified by Southwestern blotting 
are distributed in the same tissues in which the gene of interest is expressed (Ray & 
Miller 1991). 
However, direct proof linking proteins identified by gel shift assay and Southwestern 
blotting can only be provided if the proteins are purified or extracted from the gel shift 
assay. Multi-protein complexes binding to a specific DNA region may include proteins 
that do not bind to DNA directly (so will not be identified by Southwestern blotting), but 
are involved in protein-protein interactions within the complex. By identifying all the 
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proteins present in a shifted complex (by extraction of proteins from a gel shift assay) and 
identifying DNA-binding proteins by Southwestern blotting, an informative picture of the 
DNA binding complex can be created (De Belle et. al. 1991). 
1.4. Objectives. 
The objective of this dissertation was to further characterise UGPB, the promoter binding 
factor interacting with the -194/+9 region of the uteroglobin promoter. Attempts at 
purifying UGPB have met with limited success, although the conditions under which it 
binds in the gel shift assay have been further characterised and a footprint established in 
the -170/-81 region. Southwestern blotting was used to identify proteins that bind the 
-194/+9 region of the uteroglobin promoter and to establish whether they correspond to 
the MW 115000 and 94 000 proteins identified by Rider & Peterson (1991). Several 
approaches were used to further investigate the characteristics of these proteins, such as 
the region of the uteroglobin promoter they bind to, the specificity with which they bound 
the uteroglobin promoter and their presence in different tissues and after different 
hormone treatments. Attempts were also made to directly relate the proteins detected by 
Southwestern blotting with UGPB by extracting UGPB from a gel shift assay. 
2.1. Introduction. 
CHAPTER 2 - METHODOLOGY 
Establishing pl0S/p70. 
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Rider & Peterson (1991) identified two proteins specific to progesterone stimulated 
endometrium that bound the -194/-68 region of the uteroglobin promoter. However, the 
Southwestern blot shows these proteins binding much less efficiently than UGPB in a gel 
shift assay, needing 5-7 days exposure to Kodak X -Omat AR film to be visible whereas a 
strong UGPB shift is visible after a few hours of exposure to X-ray film. As discussed in 
Chapter 1, this may be due to high salt and Mg++ concentrations in the wash buffer. 
Attempts were initially made to repeat the results of Rider & Peterson (1991). When this 
proved impossible, features of the Southwestern blotting protocol were varied to identify 
the reason for the low binding activity. Several wash conditions were trialled, along with 
varying the binding buffer and the inclusion of a denaturation/renaturation step. These 
experiments identified proteins that bound to the -194/+9 region of the uteroglobin 
promoter that may be different to those identified by Rider & Peterson (1991) and 
revealed correlations between the binding activity of these proteins and that of UGPB. 
2.2. Materials & Methods. 
2.2.1. Nuclear extracts. 
Endometrial nuclear protein extracts were provided by Chris Molloy and Phillip Daniel 
of Lincoln University. 
a) Hormone treatments. 6 New Zealand white virgin female rabbits (approx. 3.5kg) 
were injected sub-cutaneously for 5 days with 3mg progesterone per kg rabbit. 
Progesterone was supplied by Sigma and dissolved in Healtheries cold pressed sesame 
oil. 10 New Zealand white virgin female rabbits (approx. 3.5kg) were not treated with 
hormones and the extract (-H extract I), which does not contain UGPB, was used as a 
negative control. 
b) Extraction. Nuclear proteins were isolated from the endometrium according to the 
protocol described in Appendix 6. Two extracts containing UGPB from progesterone-
dominated p5 endometrium were used: a crude extract (P5 crude extract I) and an 
heparin-agarose purified extract (HAG purified p5 extract I). 
2.2.2. Electrophoresis. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was carried out in a Bio-Rad 
Mini-Protean IT electrophoresis unit as detailed in Appendix 1. 0.625J,Lg Bio-Rad SDS-
PAGE Molecular Weight Standards (High Range Specificity) was always included. 
2.2.3. Electroblotting. 
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After separation, proteins were transferred from the polyacrylamide gel to Millipore 
Immobilon-P Transfer Membrane by electroblotting as in Appendix 2. After transfer, the 
region of membrane containing the molecular weight markers was excised and stained 
with amido black as in Appendix 3 for calculation of the molecular weight of proteins 
revealed by Southwestern blotting and to gauge the efficiency of transfer. 
2.2.4. Probes. 
The -194/+9 (UG200) region of the uteroglobin promoter was labelled with [a-32P]dCfP 
provided by Amersham as described in Appendix 7. 
2.2.5. DNA-protein interactions (Gel shift assays and Southwestern blotting). 
Southwestern blotting was carried out as detailed in Appendix 4. Membranes were 
exposed to Kodak X-Omat AR film with an intensifier for 2-7 days. 
2.3. Results and Discussion. 
2.3.1. Wash conditions. 
a) Rider & Peterson (1991) wash conditions I. 
Conditions for Southwestern blot: Each membrane section was blocked with 5mL 
blocking buffer and incubated with 12ng double end labelled UG200 in 5mL binding 
buffer, as described in Appendix 4. One section was washed as in Appendix 4, the other 
had two 1 hour washes in the wash buffer described by Rider & Peterson (1991) [lOmM 
HEPES (pH 8.0); 300mM NaCI; lOmM MgCI2; O.lmM EDTA; ImM DTT; 0.25% non-
fat dry milk]. 
Plate 1. Rider & Peterson (1991) wash conditions I 
Protein samples. Lanes 1 & 5: OJ,Lg protein; 2 & 6: lOJ,Lg HAG purified p5 extract I; 3 & 
7: 20J,Lg HAG purified extract 1; 4 & 8: 20J,Lg crude -H extract I. 
Wash conditions: Lanes 1-4: Rider & Peterson (RIP); 5-8: Appendix 4 (A4). 
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Plate 1 shows that Southwestern blotting detected several UG200 binding proteins 
specific to progesterone-dominated endometrium. Lanes 6 and 7 show three major 
proteins, MW 164kDa, 99.5kDa and 61.5kDa and two minor proteins, MW 140kDa and 
89.5kDa, present in HAG purified p5 extract (lane 3) and not crude -H extract (lane 4). 
All three major proteins give much stronger signals than the proteins pictured by Rider & 
Peterson (1991), with major bands being visible after only 2 days exposure to X -ray film, 
whereas Rider & Peterson (1991) exposed their membranes for 5-7 days. The strong 
molecular weight 23.4kDa signal in -H crude extract may be a protein specific to tissues 
in which uteroglobin is not expressed and so function as a repressor. Alternatively it may 
be the endometrium-specific TAT A box binding protein identified by Misseyani et. al. 
(1991). Rider & Peterson (1991) also report low molecular weight proteins (33000 and 
15 000) that bind to the -194/-68 region, but are not specific to progesterone stimulated 
endometrium. 
No proteins that bound UG200 were identified following the Southwestern blotting 
protocol of Rider & Peterson (1991), so correlation of proteins identified by the modified 
protocol with those Rider & Peterson (1991) assert are involved in the UGPB complex is 
not possible. However, Rider & Peterson (1991) used crude p5 extract in their 
experiments and the proteins they identified may have been lost in heparin-agarose 
purification. As a result, the experiment was repeated including crude p5 extract. 
b) Rider & Peterson wash conditions II. 
Conditions for Southwestern blot: As in 2.3.1.a. 
Plate 2. Rider & Peterson wash conditions II 
Protein samples. Lanes 1 & 4: 20JJ.g crude p5 extract I; 2 & 5: 20JJ.g HAG purified p5 
extract I; 3 & 6: 20JJ.g crude -H extract I. 
Wash conditions: Lanes 1-3: Rider & Peterson (RIP); 4-6: Appendix 4 (A4). 
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The Southwestern blotting protocol described by Rider & Peterson (1991) did not 
identify any proteins in crude extract that bound UG200, whereas with the modified wash 
procedure, several proteins were identified. In lane 5, the two proteins with molecular 
weights of 112kDa and 80kDa probably correspond to the 99.5kDa and 61.5kDa proteins 
identified in Plate 1. Accurate estimation of molecular weight is difficult, as the size of 
the polyacrylamide gel used means that little separation is achieved. Furthermore, 
molecular weights are being estimated from markers stained on the membrane. If the 
membrane is not precisely aligned with the top of the gel during transfer, the position of 
the molecular weight markers estimated from the membrane will not correlate directly 
with their position on the gel. These two proteins were the only two proteins to appear 
regularly in HAG purified p5 extract. Their molecular weight appears to be around 
105kDa and 70kDa and they are hereafter referred to as pI 05 and p70. 
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Lane 4 (crude p5 extract) of Plate 2 also reveals that there are proteins present in crude p5 
extract that bind UG200 which are removed by HAG purification. The molecular weights 
of these two proteins, 112kDa and 90.5kDa corresponds closely to the two proteins 
identified by Rider & Peterson (1991). The effect of HAG purification on the presence of 
these proteins is investigated in more detail in Chapter 3. The strong low molecular 
weight bands in both lanes 4 and 6 suggest that the 23.4kDa protein discussed above is 
present in the endometrium regardless of hormone status and may be removed by 
heparin-agarose purification. 
Repetition of the Southwestern blotting protocol described by Rider & Peterson (1991) 
with crude nuclear extract did not reveal any proteins that bound UG200. This may due to 
dissociation of the UGPB complex during the wash step. The Southwestern blotting 
protocol described by Rider & Peterson (1991) includes a 1-2 hour wash in buffer 
containing 300mM NaCl and lOmM MgC12. These conditions have been shown to be 
inhibitory to UGBP binding activity in gel shift assays, wherein the dissociation rate of 
the UGPB complex is increased in high concentrations of salt and magnesium ions (P. 
Daniel, personal communication). High salt concentrations are included in Southwestern 
blotting to eliminate non-specific binding, but it is not uncommon for specific DNA-
binding proteins to be susceptible to high salt concentration. During affinity purification 
of the HeLa cell protein TEF-1 which binds SV 40 enhancer motifs, TEF-1 is eluted from 
the affinity column at 300mM KCI and similarly during affinity purification of a rat liver 
cellular protein that binds cis regulatory elements of the herpes simplex virus immediate 
early genes, 300mM KCl is sufficient to disrupt proten-DNA interactions (Davidson et. 
a!. 1988; LaMarco & McKnight 1989). 
The two wash conditions compared above also differ in several parameters other than salt 
and Mg++ concentration: length of wash (20 minutes cf. 120 minutes), buffer used 
(Hepes cf. Tris), pH (8.0 cf. 7.5), EDT A concentration (0.1mM cf. 1.0mM) and the salt 
used (NaCl cf. KCl). Yet the binding buffer used in both protocols is identical to the 
Rider & Peterson (1991) wash buffer apart from the salt concentration. As binding was 
observed after incubation in this binding buffer, none of these factors can be precluding 
interaction between proteins and UG200. The wash condition described by Rider & 
Peterson (1991) must therefore be promoting dissociation of protein-UG200 complexes. 
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The three most likely factors, salt and Mg++ concentration of the wash buffer and length 
of wash were investigated. 
c) Varying length of wash, Mg++ and salt concentrations. 
Conditions for Southwestern blot: Membrane was blocked in 5mL blocking buffer and 
incubated with 24ng double end labelled UG200 in 3mL binding buffer. The lanes were 
then separated and washed as in Appendix 4, with the following alterations: 
1. 1mM MgC12; 40mM KCI; 2 * 10 minutes wash. 
2. 1mM MgC12; 40mM KCI; 2 * 30 minutes wash. 
3. Wash buffer as in Rider & Peterson (1991) [lOmM HEPES (pH 8.0); 300mM NaCl; 
lOmM MgCI2; O.lmM EDTA; 1mM DTT; 0.25% non-fat dry milk], but with 1mM 
MgCI2, 40mM NaCI; 2 * 30 minutes wash. 
4. Wash buffer as in 3, lOmM MgCI2, 40mM NaCI; 2 * 30 minutes wash. 
5. Wash buffer as in 4, 75mM NaCl. 
6. Wash buffer as in 4, lOOmM NaCl. 
7. Wash buffer as in 4, 200mM NaCl. 
8. Wash buffer as in 4, 300mM NaCl. 
Plate 3. Varying length of wash, Mg++ and salt concentrations 
Protein samples: Lanes 1-8: 20J,.Lg crude p5 extract I. 
Wash conditions: Lanes 1-8: as outlined above. 
23 
Comparison of lanes 1 and 2 of Plate 3 show that the length of wash is not having a major 
impact on the stability of the protein-DNA complex, as binding activity is similar after 2 
* 10 minute washes and 2 * 30 minute washes. Some minor bands are eliminated in lane 
2, suggesting these protein-DNA interactions are not stable. However, lane 3 
demonstrates that the Rider & Peterson (1991) buffer is causing dissociation of the 
protein-DNA complex. Lanes 2 and 3 differ only in the composition of the buffer (Hepes 
cf. Tris, pH 8.0 cf. 7.S, EDTA concentration and NaCI cf. KCI), not in salt concentration, 
Mg++ concentration or length of wash, yet binding activity of most proteins is eliminated 
in lane 3. As stated above, essentially the same buffer is used in the binding step, so it is 
obviously not interfering with protein-DNA binding. It is likely therefore that one of 
these components is affecting the stability of the protein-DNA complex. One possibility 
is the use of NaCI in the Rider & Peterson (1991) wash buffer, as Na+ ions have a much 
higher charge density than K+ ions and such factors are important in high performance 
liquid chromatography. Again the results of Rider & Peterson (1991) were unable to be 
repeated (lane 8), even after long exposure. The low molecular weight protein (16kDa) is 
not affected by the change in wash conditions, suggesting a more stable interaction. 
2.3.2. Binding conditions. 
a) Binding in TGEM 100/5 (standard binding conditions for the gel shift assay). 
Conditions for Southwestern blot: The membrane was blocked in SmL blocking buffer. 
Membrane was halved and each half was incubated separately with 12ng double end 
labelled UG200 in SmL TGEM 1OO/S [20mM Tris (pH7.S0; lS% glycerol; 1mM EDTA; 
5mM MgC12; 5mM DTI]. One half was washed as in Appendix 4, the other had two 1 
hour washes in the wash buffer described by Rider & Peterson (1991) [lOmM HEPES 
(pH 8.0); 300mM NaCI; lOmM MgCI2; O.lmM EDTA; ImM DTT; 0.25% non-fat dry 
milk]. 
24 
Plate 4. Binding in TGEM 100/5 (standard binding conditions for the gel shift assay) 
Protein samples: Lanes 1 & 5: OJ,J.g protein; 2 & 6: lOJ,J.g HAG purified p5 extract I; 3 & 
7: 20J,J.g HAG purified extract 1; 4 & 8: 20J,J.g crude -H extract 1. 
Wash conditions: Lanes 1-4: Rider & Peterson (RIP); 5-8: Appendix 4 (A4). 
The binding conditions used in gel shift assays are very different to those used in the 
binding step of the Southwestern blotting protocol. Apart from the proteins being free in 
solution, binding takes place in TGEM 100/5 [20mM Tris (pH 7.5); 15% glycerol; ImM 
EDT A; 5mM MgCI2; 5mM DTI]. If pI 05 and p70 are involved in the UGPB complex, 
they should also be able to bind UG200 in TGEM 100/5. Plate 4 demonstrates that they 
are able to do so. Lanes 6 and 7 show a strong p 105 signal and a very weak p70 signal is 
also visible. This pattern could be interpreted to suggest the TGEM 100/5 binding 
conditions are more stringent and eliminate non-specific binding, so p70 could be a non-
specific protein. However, this pattern of a weak or absent p70 signal is often observed 
and may instead indicate there is more p105 in the HAG purified p5 extract, or that it has 
a higher affinity for UG200. If p70 is a low affinity protein, this may explain why Rider 
& Peterson (1991) did not detect it in their wash conditions. The absence of a low 
molecular weight band in the -H extract is not unusual either. Like several weak bands in 
the p5 extracts, its appearance is irregular. Again, no proteins that bound UG200 were 
observed following the wash protocol of Rider & Peterson (1991). 
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b) Varying Mg++ concentration of binding buffer. 
Conditions for Southwestern blot: The membrane was blocked in 5mL blocking buffer. 
Each HAG pS/-H pair was then separated and incubated with 4.8ng double end labelled 
UG200 (see Appendix 7) in 0.5mL binding buffer made 2.5mM MgCl2, 5.0mM MgCl2, 
10.0mM MgCl2 and 15.0mM MgCL2 respectively. 
Plate 5. Varying Mg++ concentration of binding buffer 
Proten samples: Lanes 1,3,5 & 7: 20J,Lg HAG purified p5 extract I; 2,4,6 & 8: 20J,Lg 
crude -H extract 1. 
Binding conditions: Lanes 1 & 2: 2.5mM Mg++; 3 & 4: 5.0mM Mg++; 5 & 6: 1O.0mM 
Mg++; 7 & 8: 15.0mM Mg++. 
As mentioned above, the concentration of Mg++ ions has been shown to have an 
important role in determining the stability of the UGPB complex. Plate 5 shows the result 
of varying the Mg++ concentration of the binding buffer. Comparison of lanes 1,3,5 & 7 
shows that both p 105 and p70 give a stronger signal at low Mg++ concentrations, hence 
the binding parameters of both proteins correlates with that of UGPB. The faint band in 
lane 5 has a molecular weight of 180kDa and is probably the same protein that gave a 
strong signal in 2.2.1.a (Plate 1, lane 7). This protein (hereafter termed p 180) also appears 
irregularly in HAG p5 extract. 
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2.3.3. DenaturationlRenaturation. 
Conditions for Southwestern blotting: One half of the membrane was blocked in 5mL 
blocking buffer and incubated in 2mL TGEM 100/5 with 12ng double end labelled 
UG200. The other half was denatured and renatured as in Appendix 5. After renaturation, 
the mem brane was treated in parallel to the other half. 
Plate 6. Denaturation/Renaturation 
Protein samples: Lanes 1 & S: Of.J.g protein; 2 & 6: lOf.J.g HAG purified pS extract I; 3 & 
7: 20f.J.g HAG purified extract 1; 4 & 8: 20f.J.g crude -H extract I. 
Binding conditions: Lanes 1-4: DenaturedlRenatured; S-8: Not DenaturedlRenatured. 
Although the modified Southwestern blot protocol identified proteins that bind UG200, 
the binding activity is much lower than the activity of UGPB in gel shift assays, wherein 
4f.J.g of HAG purified p5 extract can show a strong shift after a few hours exposure to X-
ray film. Much of the loss of activity may be due to denaturing of the proteins in the 
Southwestern blotting process. Some researchers include a denaturation/renaturation step 
in an attempt to allow membrane bound proteins to resume an active conformation after 
electroblotting. Plate 6 shows the result of including a denaturation/renaturation step in 
the protocol. Lanes 3 and 4 show numerous proteins in heparin-agarose endometrium that 
bind UG200 after denaturation/renaturation, with major bands at I60kDa and II7kDa 
(pI0S). By contrast without a denaturation/renaturation step, only one protein is visible 
(lanes 6 & 7). The molecular weight of this protein was not able to be established as the 
top of the membrane is not visible, but it is likely to be plOS. However, it is clear that 
denaturation is a problem in the Southwestern blotting protocol. The experiments 
following did not include a denaturation step for simplicity. p105 and p70 bind UG200 
strongly, so are the best candidates for UGPB and both can be identified without a 
denaturation/renaturation step. 
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The numerous proteins in HAG purified p5 extract able to bind UG200 after renaturation 
may be non specific DNA-binding proteins. UG200 is a relatively long stretch of DNA, 
so binding sites for other specific DNA-binding proteins could also be present. 
Alternatively, the minor bands, which are occasionally visible without renaturation, may 
be precursors or proteolytic cleavage products of the major components, pl05 and p70, 
that have retained their DNA binding activity. The nuclear extraction procedure (see 
Appendix 6) involves several protease inhibitors and proteolytic degradation is a major 
problem during the extraction procedure. It is interesting to note that p 105 and p70 may 
themselves be proteolytic cleavage products ofpl80, but only ifp180 has two DNA 
binding sites to allow both fragments to retain DNA binding activity. This is unusual, but 
there is a precedent. Fan & Maniatis (1990) report isolation of a 298kDa DNA-binding 
protein containing two widely separated C2H2 zinc fingers, both of which bind the same 
DNA sequence motif. Fragments containing only one set of zinc fingers can still bind this 
motif. Alternatively, p70 may be a cleavage product of p 105. 
2.4. Conclusions. 
The results of Rider & Peterson (1991) were unable to be repeated and experiments 
suggest that some factor in the wash buffer used by Rider & Peterson (1991) other than 
salt concentration, Mg++ concentration and length of wash, is promoting the dissociation 
of protein-UG200 complexes. Two proteins of molecular weight 11 OkDa (p 105) and 
70kDa (p70) were identified in HAG purified p5 extract that bind UG200 strongly. These 
proteins have some similar binding parameters to UGPB, being able to bind UG200 in 
TGEM 100/5 and having increased affinity for UG200 at low Mg++ concentrations. 
Several other minor bands appear irregularly and their affinity for UG200 is greatly 
increased by the inclusion of a denaturation/renaturation step in the protocol. These 
proteins may be proteolytic cleavage products of p 105 and p70, or other DNA-binding 
proteins present in low quantities. One of these with a molecular weight of 180kDa 
(p 180) appears more regularly and may be a precursor of both p 105 and p70. For all 
future experiments, the Southwestern blotting methodology was carried out exactly as 
described in Appendix 4. 
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CHAPTER 3 - PURIFICATION OF UGPB. 
Are pl0S/p70 co-purified with UGPB? 
3.1. Introduction. 
Plate 2 illustrated that there is at least one protein that binds UG200 in crude p5 extract 
that is removed by heparin- agarose purification and that the relative concentration of p70 
appears to increase with heparin-agarose purification. The co-purification of p 105 and 
p70 with UGPB is good indirect evidence that these proteins are involved in the UGPB 
complex. However, the crude p5 extract used in 2.3.l.b. has a KCI concentration of 
400mM, whereas the HAG purified p5 extract has a KCI concentration of 250mM. Salt 
concentration can have an important effect on the mobility of proteins through an SDS 
gel as the salt anions in a sample enter the gel first, slowing protein entry. If all samples 
do not contain the same salt concentration, comparison of protein mobility between the 
lanes will be inaccurate. 
Extracts from several stages in the heparin-agarose (HAG) purification and affinity 
purification process were subjected to Southwestern blotting to establish whether p 105 
and p70 were co-purified with UGPB. All extracts were made 250mM KCI to make 
meaningful comparison between the fractions possible. A gel shift assay of the same 
samples allowed correlation between the presence of UGPB during purification 
procedures and the presence of pI 05/p70 in these samples. 
3.2. Materials & Methods. 
3.2.1. Nuclear extracts. 
Endometrial nuclear protein extracts were provided by Chris Molloy and Phillip Daniel, 
Lincoln University. 
a) Hormone treatments. 6 New Zealand white virgin female rabbits (approx. 3.5kg) 
were injected sub-cutaneously for 5 days with 3mg progesterone per kg rabbit. 
Progesterone was supplied by Sigma and dissolved in Healtheries cold-pressed sesame 
oil. 
b) Extraction. Nuclear proteins were isolated from the endometrium according to the 
protocol described in Appendix 6. Samples were taken from various stages of UGPB 
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purification, which involves DEAE-cellulose, heparin-agarose, cellulose-phosphate and 
affinity column purification. 
3.2.2. Electrophoresis. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was carried out in a Bio-Rad 
Mini-Protean II electrophoresis unit in 3.3.1.a and in parts 3.3.1.b and c in a Bio-Rad 
Protean I as in Appendix 1. 0.625J.Lg Bio-Rad SDS-PAGE Molecular Weight Standards 
(High Range Specificity) was always included. 
3.2.3. Electroblotting. 
After separation, proteins were transferred from the polyacrylamide gel to Millipore 
Immobilon-P Transfer Membrane by electroblotting as in Appendix 2. After transfer, the 
region of membrane containing the molecular weight markers was excised and stained 
with Amido Black as in Appendix 3 for calculation of the molecular weight of proteins 
revealed by Southwestern blotting and to gauge the efficiency of transfer. 
3.2.4. Probes. 
The -194/+9 (UG2OO) region of the uteroglobin promoter was labelled with [a-32P]dCTP 
provided by Amersham as described in Appendix 7. 
3.2.5. DNA-protein interactions (Gel shift assays and Southwestern blotting). 
Southwestern blotting and gel shift assays were carried out as detailed in Appendices 4 
and 8 respectively. Poly dldC was provided by Boehringer-Mannhiem. Membranes and 
dried gels were exposed to Kodak X-Om at AR film with an intensifier for 2-7 days. 
3.3. Results and Discussion. 
3.3.1. Heparin-agarose Purification. 
a) Gel shift assay. 
Conditions for gel shift assay: Proteins and double end labelled UG200 incubated at 
l00mM KCl. 
2 3 4 5 6 
Plate 7. HAG purification: Gel shift assay 
7 8 9 
-UGPB 
Shift 
-Free 
Probe 
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Protein samples: Lane 1: OJ,Lg protein; Lane 2: 21.6J,Lg Fraction I (crude extract); 3: 6J,Lg 
Fraction III (Flowthrough from DEAE cellulose column); 4-8: 4J,Lg, 9.1 J,Lg, 8.2J,Lg, 7.0J,Lg 
and 4.0J,Lg of Fractions 5-9 respectively (250mM KCl elution from Heparin-agarose 
column); 9: 11.6J,Lg Fraction 10 (500mM KCl elution from Heparin-agarose column). 
Plate 7 demonstrates that UGPB is present in the crude p5 extract I (lane 2), in low levels 
in Fraction III (lane 3) and is eluted from the heparin-agarose column at 250mM KCl 
(lanes 5-8). No UGPB was detected in Fraction 5 (lane 4) or in the 500mM KCl elution 
from the heparin-agarose column (lane 9). 
b) Southwestern blot - 6cm * 8.3cm gel. 
Conditions for Southwestern blot: The membrane was blocked in 5mL blocking buffer 
and incubated in 2.5mL binding buffer with 24ng double end labelled UG200. 
kDa 
197 
124 
116 
86 
46 
22 
Plate 8. HAG purification: Southwestern blot - 6cm * 8.3cm gel 
Protein samples. Lane 1: 33.75J,.Lg Fraction I (crude extract); 2: 15J,.Lg Fraction III 
(Flowthrough from DEAE cellulose column); 3: 3J,.Lg Fraction 1 (150mM KCl elution 
from Heparin-agarose column); 4-8: lOJ,.Lg, 22.75J,.Lg, 20.5J,.Lg, 17.5J,.Lg and lOJ,.Lg of 
Fractions 5-9 respectively (250mM KCl elution from Heparin-agarose column); 9: 
1 1. 6 J,.Lg Fraction 11 (500mM KCl elution from Heparin-agarose Column). All fractions 
were made 250mM KCl. 
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Plate 8 indicates that crude p5 extract contains four major proteins that bind UG200, with 
molecular weights 197kDa (pI80), 124kDa, 116kDa and 86kDa (p70). The pair of 
proteins at 124kDa and 116kDa probably correspond to the 115kDa and 94kDa proteins 
identified by Rider & Peterson (1991). Only one of these two proteins is present in lanes 
5-9 and is therefore co-purified with UGPB. However, the poor separation achieved in 
this gel makes it difficult to determine which of the pair is purified. Because of this, the 
same protein fractions were run on a 13 Acm * 16.2cm gel to achieve better separation. 
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c) Southwestern blot· 13.4cm * 16.2cm gel I. 
Conditions for Southwestern blot: The membrane was blocked in lOmL blocking buffer 
and incubated in lOmL binding buffer with 36ng double end labelled UG200. 
Plate 9. HAG purification: Southwestern blot· 13.4cm * 16.2cm gel I 
Protein samples. Lane 1: 202.5 ~g Fraction I (crude extract); 2: 90~g Fraction III 
(Flowthrough from DEAE cellulose column); 3-7: 603~g, 136.5~g, 123~g, 105~g and 
60~g of Fractions 5-9 respectively (250mM KCI elution from Heparin-agarose column); 
8: 87 ~g Fraction 11 (500mM KCI elution from Heparin-agarose column); 9: 202.5~g 
Fraction I (crude extract). All fractions were made 250mM KCl. 
Plate 9 shows some of the same proteins in crude p5 extract (lane 1) as Plate 8, although 
p 180 is not visible and both p70 and the 124kDa protein are relatively faint. Interestingly, 
p70 and a 27kDa protein are present in Fractions 6 and 7 (lanes 4 & 5), so are co-purified 
with UGPB, but neither of the 124kDa and 115kDa proteins appear to be. This may be a 
result of the large volume of binding buffer the membrane was incubated in. In this 
volume of buffer, relatively little of the probe will be in contact with the membrane and 
some regions of membrane may not be exposed to the probe at all. Because of this, the 
experiment was repeated with 48ng of double end labelled UG200 in the binding step. 
d) Southwestern blot· 13.4cm * 16.2 cm gel H. 
Conditions for Southwestern blot: As in 3.3.1.c., but membrane incubated in lOmL 
binding buffer containing 48ng double end labelled UG200. 
Plate 10. HAG purification: Southwestern blot - 13.4cm * 16.2 cm gel IT 
Protein samples. Lane 1: 202.5 tLg Fraction I (crude extract); 2: 90 tLg Fraction III 
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(Flow through from DEAE cellulose column); 3-7: 603tLg, 136.5tLg, 123tLg, 105tLg and 
60 tLg of Fractions 5-9 respectively (250mM KCI elution from Heparin-agarose column); 
8: 87 tLg Fraction 11 (500mM KCI elution from Heparin-agarose column); 9: 202.5tLg 
Fraction I (crude extract). All fractions were made 250mM KCl. 
Although again only some of the regularly identified proteins are visible, Plate 10 shows 
clearly that of the pair of proteins at 122kDa and 113kDa in crude p5 extract, only the 
113kDa protein (p105) is co-purified with UGPB. If these two proteins are the proteins 
identified by Rider & Peterson (1991), then one must have no role in the UGPB complex. 
Although the molecular weights are different from those identified by Rider & Peterson 
(1991), Rider & Peterson (1991) used 14C labelled molecular weight markers rather than 
amido black stained markers and this may account for the discrepancy between the two 
results. The proteins identified by Rider & Peterson (1991) migrate close together, so are 
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certainly not p105 and p70, which are widely spaced even on a 6.3cm * 8.2cm gel. 
Furthennore, molecular weight is calculated by correlating the log of the molecular 
weight of the markers and the distance the markers have migrated and using a line of best 
fit to estimate a relationship. Direct comparison of amido black stained markers and a 
Southwestern blot show p 105 running just behind the 97.5kDa marker and well in front 
of the 116.25 marker, suggesting it could well be the 94kDa protein identified by Rider & 
Peterson (1991). 
3.3.2. Affinity Purification. 
a) Gel shift assay. 
Conditions for gel shift assay: Proteins and double end labelled UG200 incubated at 
340mM KCl. 
Plate 11. Affinity purification: Gel shift assay 
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Protein samples. Lane 1: OtLg protein; 2: 57 tLg crude extract; 3: 14.4tLg flowthrough from 
DEAE cellulose column; 4: 55.2tLg 500mM KCl wash from Heparin-agarose column; 5: 
1O.2tLg dialysed flowthrough from cellulose-phosphate column passage I; 6: 2.64tLg 
flow through from cellulose-phosphate column passage II; 7: 4.62tLg 300mM KCl eluate 
from cellulose-phosphate column passage II; 8: O.6tLg flow through from affinity column; 
9: 3.96tLg O.3M KCl eluate from affinity column; 10: 27.3tLg HAG purified p5 extract I 
(positive control). 
The flowthrough from the affinity column (with the UGPB footprint site linked to solid 
matrix) is the only fraction that does not contain UGPB. Although the UGPB shift is not 
readily visible in lane 9, the O.3M KCl eluate from the affinity column, longer exposure 
confirms the presence of a UGPB shift. The variation in mobility of the UGPB shift 
demonstrated in Plate 11 (eg. lane 4 cf. lane 5) is not uncommon in the gel shift assay and 
is the result of overloading of proteins (eg lane 4 55.2tLg cf. lane 5 1O.2tLg). The disparity 
in the amount of protein loaded into each lane is a consequence of equalising the salt 
concentrations of each sample, which is important for reasons discussed above. 
b) Southwestern blot. 
Conditions for Southwestern blot: The membrane was blocked in 5mL blocking buffer 
and incubated with 18ng double end labelled UG200 in 2mL binding buffer. 
Plate 12. Affinity purification of UGPB: Southwestern blot 
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Protein samples. Lane 1: 57 fJ.g crude extract; 2: 14.4fJ.g flow through from DEAE 
cellulose column; 3: 55.2fJ.g 500mM KCI wash from Heparin-agarose column; 4: lO.2fJ.g 
dialysed flowthrough from cellulose-phosphate column passage I; 5: 2.64fJ.g flowthrough 
from cellulose-phosphate column passage II; 6: 4.62fJ.g 300mM KCI eluate from 
cellulose-phosphate column passage II; 7: 0.6fJ.g flow through from affinity column; 8: 
3.96fJ.g 0.3M KCI eluate from affinity column; 9: 27.3fJ.g HAG purified p5 extract I 
(positive control). All samples were made 340mM KCI and incubated in 1 % SDS sample 
buffer before electrophoresis. 
Plate 12 demonstrates two important points about the affinity purification process. 
Firstly, it indicates the inclusion of a cellulose phosphate column in the purification 
process is eliminating several UG200 binding proteins that remain after HAG purification 
(lanes 4-6 cf. lane 3). Southwestern blotting may therefore be an informative method to 
follow the purification procedure. Secondly, after affinity purification, only one major 
protein remains, p 105, suggesting that pi 05 is involved in the UGPB complex. This is 
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most graphically demonstrated by the affinity column flow through (lane 7) which does 
not contain UGPB and does not contain p 105 (lanes 1-6, 8 and 9). All other lanes that 
produce a UGPB shift contain p105. p105 also appears to be concentrated by the affinity 
purification procedure, as lane 8 contains 3.96J.Lg of protein and the p105 band is of 
comparable intensity to that produced by 27.3 J.Lg HAG purified p5 extract 1. 
This result cannot eliminate the possibility that other proteins are involved in the UGPB 
complex. Many of the proteins present in HAG purified p5 extract I appear irregularly 
and some of these may also be present in the affinity purified extract. Furthermore, as 
will be discussed in Chapter 8, the Southwestern blotting procedure, by physically 
separating proteins, may intrinsically preclude the binding of some proteins that are 
involved in the UGPB complex in the gel shift assay. The fact that the O.3M KCI affinity 
column eluate gives a relatively weak UGPB shift (see Plate 11) may indicate the absence 
of other proteins that stabilise the UGPB complex. However Plate 12 demonstrates that 
pl05 is co-purified with UGPB in a process that eliminates most UG200 binding 
proteins. This is strong evidence that p105 is involved in the UGPB complex. 
3.4. Conclusions. 
Both p 105 and p70, along with a protein of molecular weight 27kDa are co-purified with 
UGPB during heparin-agarose purification and p105 is co-purified with UGPB during 
affinity purification, a process that eliminates several UG200 binding proteins. pl05 
appears to be the 94 kDa protein identified by Rider & Peterson (1991), but the 115kDa 
protein identified by them is not co-purified with UGPB, so must not playa part in the 
UGPB complex. However, direct correlation of p105 and the 94kDa protein is not 
possible as the results published by Rider & Peterson (1991) were unable to be repeated, 
as discussed in Chapter 2. Taken with the results in Chapter 2, the co-purification of pi 05 
with UGPB provides strong indirect evidence that p105 is involved in the UGPB 
complex. Further analysis of affinity purification fractions is needed to determine the role 
of p70. 
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CHAPTER 4 - COMPETITION SOUTHWESTERN BLOTTING. 
Do plOS/p70 bind specifically to the Uteroglobin Promoter? 
4.1. Introduction. 
Chapters 2 & 3 demonstrate the presence of several proteins in HAG purified p5 extract I 
that bind UG2oo: two major proteins (p 105 and p70) and several minor proteins whose 
affinity for UG200 is increased by allowing membrane bound proteins to renature after 
electroblotting. Some or all of these proteins may be components of UGPB, but they may 
also be non-specific DNA-binding proteins such as histones. The wash step of the 
Southwestern binding protocol is designed to eliminate non-specific binding by the 
inclusion of high concentrations of salt (eg. 300mM NaCl). However, Chapter 2 
established that such a wash buffer causes dissociation of UG200 binding protein 
complexes and the wash buffer used (40mM KCl) is unlikely to eliminate non-specific 
binding. 
In gel shift assays, the specificity of protein-DNA interaction is tested by the inclusion of 
competing DNA in the incubation mixture. A large excess of non-specific competitor 
DNA such as dldC is included in most gel shift incubations. DNA-binding proteins that 
do not interact specifically with the probe bind to dldC and are therefore are not available 
to bind the labelled probe. Specific DNA-binding proteins will not bind dldC. However, 
inclusion of a 20 or 100 fold excess of unlabelled probe will prevent most specific DNA-
binding proteins from binding labelled probe. Non-specific DNA-binding proteins are 
thought to be present in much higher quantities, so they will still bind large amounts of 
labelled probe in the presence of excess unlabelled probe. UGPB is a specific DNA 
binding complex. The inclusion of a 20 fold excess of unlabelled UG200 is sufficient to 
almost eliminate the UGPB shift, whereas a 6666 fold excess of dldC will not. However, 
UGPB is only relatively specific as it can also be competed by dAdT and AT rich regions 
of the Bluescript plasmid, although neither of these compete as efficiently as UG200 (P. 
Daniel, personal communication). 
Competition experiments are not often applied to Southwestern blotting. However in this 
case, the inclusion of competing DNA in the binding step would help to establish whether 
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P 105 and p70 are specific UG200 binding proteins and therefore further help to correlate 
the binding parameters of these proteins with UGPB. Several Southwestern blots were 
carried out with the inclusion of competing DNA and the results were analysed by 
densitometry . 
4.2. Materials & Methods. 
4.2.1. Nuclear extracts. 
Endometrial nuclear protein extracts were provided by Chris Molloy and Phillip Daniel, 
Lincoln University. 
a) Hormone treatments. 6 New Zealand white virgin female rabbits (approx. 3.5kg) 
were injected sub-cutaneously for 5 days with 3mg progesterone per kg rabbit. 
Progesterone was supplied by Sigma and dissolved in Healtheries cold-pressed sesame 
oil. 10 New Zealand white virgin female rabbits were not treated with hormones and the 
extract (-H extract I), which does not contain UGPB, was used as a negative control. 
b) Extraction. Nuclear proteins were isolated from the endometrium according to the 
protocol described in Appendix 6. From the progesterone treated rabbits, a crude extract 
(P5 crude extract I) and an extract containing UGPB after heparin-agarose (HAG) 
purification were used. 
4.2.2. Electrophoresis. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was carried out in a Bio-Rad 
Mini-Protean II electrophoresis as in Appendix 1. 0.625tlg Bio-Rad SDS-PAGE 
Molecular Weight Standards (High Range Specificity) was always included. 
4.2.3. Electroblotting. 
After separation, proteins were transferred from the polyacrylamide gel to Millipore 
Immobilon-P Transfer Membrane by electroblotting as in Appendix 2. After transfer, the 
region of membrane containing the molecular weight markers was excised and stained 
with amido black as in Appendix 3 for calculation of the molecular weight of proteins 
revealed by Southwestern blotting and to gauge the efficiency of transfer. 
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4.2.4. Probes. 
The -194/+9 (UG200) region of the uteroglobin promoter was labelled with [a-32P]dCfP 
provided by Amersham as described in Appendix 7. 
4.2.5. DNA-protein interactions (Gel shift assays and Southwestern blotting). 
Southwestern blotting and gel shift assays were carried out as detailed in Appendices 4 
and 8 respectively. Poly dldC was provided by Boehringer-Mannhiem. Membranes and 
dried gels were exposed to Kodak X-Omat AR film with an intensifier for 2-7 days. 
Autoradiographs were scanned with a Hoefer GS300 TransmittancelReflectance 
Scanning Densitometer. 
4.3. Results and Discussion. 
4.3.1. Gel Shift Assay. 
Conditions for gel shift assay: HAG purified extract I incubated at 100mM KCl with 
O.6ng double end labelled UG200 and competitors as listed. 
8 
Plate 13. Competition: Gel Shift Assay 
-UGPB 
Shift 
-Free 
Probe 
Protein samples. Lane 1: 0 J,lg protein; 2-7: 20 J,lg HAG purified p5 extract I; 8: 20 J,lg 
crude -H extract 1. 
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Competitors. Lane 2 & 3: 4J,lg dldC (6666 fold excess); 4 & 5: 4J,lg dldC (6666 fold 
excess) and 12ng UG200 (20 fold excess); 6: 12ng UG200 (20 fold excess); 7 & 8: None. 
Comparison of the UGPB shift marked in lanes 2 and 3 of Plate 13 with lanes 4 and 5 
show the extent of competition by a 20 fold excess of unlabeled UG200. Most 
importantly, lanes 6 and 7 show that in the absence of dldC a different protein-UG200 
complex forms that precludes the formation of the UGPB complex. That is, there are non-
specific DNA-binding proteins in HAG purified p5 extract capable of binding UG200 
and that are competed out by a 6666 fold excess of dldC. This suggests that any or all of 
the proteins detected by Southwestern blotting may be non-specific DNA-binding 
proteins, as the reaction conditions do not include non-specific competitors or high 
stringency wash conditions. Lane 8 confirms that the -H extract does not contain UGPB, 
but the minor shifts indicates the presence of proteins able to bind UG200. 
4.3.2. Competition Southwestern System I. 
a) Competition with dIdC and UG200 I. 
. 
Conditions for Southwestern blotting: All three HAG purifiedl-H pairs were blocked 
together in 5mL blocking buffer. Each section was then incubated separately in 2mL 
binding buffer competitors as listed below. 
Plate 14. Competition Southwestern System I: dIdC and UG200 I 
Protein samples. Lanes 1,3 & 5: 20tLg HAG purified p5 extract I; 2,4 & 6: 20tLg crude 
-H extract 1. 
43 
Competitors. Lanes 1 & 2: 32tLg dldC (6666 fold excess); 3 & 4: 96ng unlabeled UG200 
(20 fold excess); 5 & 6: 32tLg dIdC (6666 fold excess) and 96ng unlabeled UG200 (20 
fold excess). 
Plate 14 shows that the inclusion of a 20 fold excess of unlabelled UG200 does not 
significantly reduce protein-DNA binding as it does in the gel-shift assay (lane 3). In fact, 
visual comparison of lanes 1 and 3 suggests that dIdC competes more effectively for pI 05 
binding than UG200. However, the p70 band appears more intense in lane 1 than lane 3, 
suggesting it is being competed more effectively by UG200 than dIdC. Densitometry 
confirmed these observations, with the pI 05 band being 11 fold more intense in the 
absence of dldC and the p70 band being 4 fold more intense in the absence of UG200, as 
measured by maximum band intensity. However, there are problems with the design of 
this experiment. As no lanes were incubated with double end labelled UG200 in the 
absence of any competitor, estimation of the efficiency of competition is limited. The 
differences in intensities observed may be random variation rather than specific 
competition. Because of this, the experiment was repeated with the inclusion of an 
uncompeted HAG purified p5 extract. 
b) Competition with dldC and UG200 H. 
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Conditions for Southwestern blotting: All HAG purifiedl-H pairs were blocked together 
in 5mL blocking buffer, then separated and incubated in 2mL binding buffer with 4.8ng 
double end labelled UG200 and competitors as outlined below. 
Plate 15. Competition Southwestern System I: dldC and UG200 n 
Protein samples. Lanes 1,3,5 & 7: 20J,Lg HAG purified p5 extract I; 2,4,6 & 8: 20J,Lg 
crude -H extract I. 
Competitors. Lanes 1 & 2: None; 3 & 4: 32J,Lg dldC (6666 fold excess); 5 & 6: 96ng 
unlabeled UG200 (20 fold excess); 7 & 8: 32J,Lg dldC (6666 fold excess) and 96ng 
unlabeled UG200 (20 fold excess). 
Visual comparison of lanes 1 and 3 in Plate 15 suggest that p 105 is being strongly 
competed by dldC, whereas p70 is being competed to a lesser extent. Densitometry 
confirmed this, with the pI 05 band being reduced in intensity 10 fold by the presence of 
dldC, whereas p70 is only reduced 3 fold, as measured by maximum band intensity. By 
contrast, densitometry of lanes 1 and 5 suggests slight competition of p70 by UG200 
(approx. 1.5 fold), whereas pI 05 is not significantly competed. 
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U0200 is obviously not having as profound a competing effect in the Southwestern blot 
as in the gel shift assay, wherein a 20 fold excess of U0200 can almost eliminate the 
shift. However, in a gel shift assay, the proteins, probe and competitor(s) are incubated in 
a total volume of 20J,LL, so proteins will be in relatively close contact with the competing 
DNA and as all components are in solution, all proteins should have access to DNA. This 
is in direct contrast to the Southwestern blot binding conditions, where the proteins are 
separated and immobilised on a membrane and the probe and competing DNA are 
suspended in 2mL binding buffer, so that much of the competing DNA and probe will not 
contact the proteins bound to the membrane. As a result, the actual excess of competitor 
to which the membrane bound proteins at any given point are being exposed may differ to 
that calculated. To obtain more meaningful competition results, it could be helpful to 
include a larger excess of competing DNA in a smaller volume of binding buffer. An 
alternative competition Southwestern blotting system was developed, by placing the 
blocked membrane face up on the inside of a tube and rolling a small volume of binding 
buffer containing the probe and competing DNA across it. 
4.3.3. Competition Southwestern System II. 
a) Competiton with UG200. 
Conditions for Southwestern blotting: The three crude/HAO purifiedl-H triplets were 
separated and blocked together in 5mL blocking buffer. The three sections of membrane 
were then placed face up on the side of a 15mL plastic tube and incubated with 0.5mL 
binding buffer so that the binding buffer rolled back and forth across the membrane. The 
binding buffer contained 4.8ng double end labelled U0200 and competitors as outlined 
below. 
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Plate 16. Competition Southwestern System IT: Competition with UG200 
Protein samples. Lanes 1,4 & 7: 20 crude p5 extract I; 2, 5 & 8: 20~g HAG purified p5 
extract I; 3,6 & 9: 20~g crude -H extract I. 
Competitors. Lanes 1,2 & 3: None; 4,5 & 6: 96ng unlabelled UG200 (20 fold excess); 7, 
8 & 9: 480ng unlabelled UG200 (100 fold excess). 
Plate 16 shows the results of competition with 0, 20 fold and 100 fold excess ofUG200. 
Unfortunately lanes 1,4 and 9, the crude p5 extract I lanes, do not give a clear enough 
pattern for densitometry. However densitometry of lanes 2, 5 and 8 confirm that p70 is 
competed to some extent by UG200. An 100 fold excess of unlabelled UG200 reduces 
the intensity of the p70 band 4 fold, as measured by maximum band intensity, whereas 
the same excess has no measurable effect on p105 band intensity. It should be noted that 
the absence of impact on p 105 band intensity may reflect the lack of sensitivity of the 
densitometer to detect changes in band intensity when the band is very intense, as the 
p105 band is in this case. However, analysis of the same membrane exposed for 8 hours 
shows no difference in intensity of the p 105 band between lanes 2, 5 and 8 (results not 
shown). The evidence so far suggests p70 is binding specifically to UG200, while p 105 is 
a relatively non-specific DNA-binding protein. The strength of the p105 signal is also 
suggestive of a non-specific DNA-binding protein, as such proteins are thought to be 
present in much higher concentrations than specific DNA-binding proteins. 
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Some protocols using competition as a measure of specificity of DNA binding pre-
incubate nuclear proteins with unlabelled probe in an attempt to prevent labelled probe 
binding. Low affinity DNA-binding proteins (as proteins that are binding DNA non-
specifically are likely to be) often have a slow "on" rate for DNA binding, in which case 
pre-incubation allows competitors more time to bind to low affinity proteins. Pre-
incubation with UG200 was attempted. 
b) Competition with UG200 including pre-incubation with competitor. 
Conditions for Southwestern blotting: As in 4.3.3.a, but after blocking, membranes were 
incubated with competitor in 0.5mL binding buffer for 1 hour before addition of 4.8ng 
double end labelled UG200 and incubation for another hour. 
Plate 17. Competition Southwestern System II: Pre-incubation with UG200 
Protein samples. Lanes 1,4 & 7: 20 crude p5 extract I; 2, 5 & 8: 20J,Lg HAG purified p5 
extract I; 3, 6 & 9: 20J,Lg crude -H extract 1. 
Competitors. Lanes 1,2 & 3: None; 4, 5 & 6: 96ng unlabeled UG200 (20 fold excess); 7, 
8 & 9: 480ng unlabeled UG200 (100 fold excess). 
Plate 17 shows that no signal was detected from p70 and the signal from p105 was 
relatively faint (lanes 2, 5 & 8). Densitometry again shows no detectable competition of 
p 105 by UG200, although the intensity of the p 105 band is not even, making meaningful 
analysis difficult. 
4.4. Conclusions. 
Competition is a relatively difficult technique to apply to Southwestern blotting, as the 
variable nature of the blotting process itself, as discussed in Chapter 8, makes 
interpretation of results difficult. However, the four blots detailed here give clear 
evidence that p70 is competed to some extent by UG200 and to a lesser degree by dIdC. 
By contrast, p105 is competed by dIdC, but UG200 caused no detectable competition. 
The simplest interpretation of these results is that p70 is binding to UG200 specifically, 
whereas p105 is relatively non-specific. However, this does not necessarily preclude p105 
from a role in the UGPB complex. For reasons discussed above, competition is having a 
less noticeable effect on binding in Southwestern blotting in comparison to the gel shift 
assay. Plate 13 established that non-specific binding is eliminated in the gel shift assay by 
a 6666 fold excess of dIdC, yet in analogous conditions in the Southwestern blot, p 105 
still displays strong binding activity and significantly greater activity than p70. If 
membrane bound p 105 is being subjected to an actual 6666 fold excess of dIdC during 
the Southwestern blot (ie. if the competitors and probe are distributed uniformly 
throughout the binding buffer), p 105 should still be able to bind UG200 in the gel shift 
assay. 
Furthermore, UGPB has been shown not to be rigorously specific in its binding activity 
by gel shift assay, as AT rich DNA like dAdT and AT rich regions of Bluescript can 
compete for UGPB binding (P. Daniel, personal communication). It could be 
hypothesised that p 105 represents a relatively non-specific component of the UGPB 
complex, whereas p70 acts as a specific component. This could be tested by examining 
whether AT rich DNA such as dAdT also compete p105. Certainly p70 and p105 appear 
to bind UG200 differently, suggesting p70 is not a cleavage product ofpl05. The 
differences in binding activity between p70 and p105 are investigated in more detail in 
Chapter 5. 
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CHAPTER 5 - pl05/p70 BINDING SITE 
Do pl05/p70 bind to the UGPB Footprint Region? 
5.1. Introduction. 
Characterising the region of the uteroglobin promoter that p105 and p70 bind to would be 
important for several reasons. Firstly, it would provide additional evidence for a role for 
p105 and p70 in the UGPB complex. DNase I footprinting of UG200 with HAG purified 
p5 extract I has revealed a single footprint over the -167/-85 region on the coding strand 
and -170/-81 on the non-coding strand (c. Molloy, personal communication). Fragments 
within this region also have some binding activity for UGPB, with fragments decreasing 
in binding activity as follows: -170/-85 > -170/-100 > -154/-100 > -170/-118. Smaller 
fragments (-154/-118 and -117/-85) showed negligible binding activity (c. Molloy, 
personal communication). Cleavage of UG200 with Ssp I, which cleaves at -130, 
resulting in two fragments -194/-130 and -129/+9, eliminates UGPB binding in the gel 
shift assay, presumably because it disrupts the UGPB binding site. If p105 and p70 
follow similar patterns of binding activity, this would be strong evidence that these 
proteins are involved in the UGPB complex. 
Secondly specific transcription factors such as TFIID or the endometrial specific factor 
identified by Misseyani et. al. (1991) that binds to the -40/-23 region of the uteroglobin 
promoter could be expected to bind UG200. However, if smaller fragments known to 
bind UGPB are used, the chance of additional specific transcription factors or non-
specific DNA-binding proteins recognising them are reduced. This reasoning may shed 
light on the role of the minor UG200 binding proteins found in crude and HAG purified 
p5 extract. If some of these proteins are precursors or derivatives of p105 and p70 or are 
distinct proteins involved in the UGPB complex, then they could be expected to bind to 
some fragments of the footprint region. 
Finally, the molecular weights of p105 and p70 are relatively close to those for the rabbit 
progesterone receptor, which co-purifies in two forms with molecular weights 105000 
and 78000 (Lamb, Kima & Bullock 1986). Bailly et. al. (1983) previously reported 
binding of progesterone receptor to the -394/+ 10 region of the uteroglobin promoter, but 
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this result was unrepeatable and is now thought to be an artifact due to co-purification of 
a promoter binding factor (Miele, CordelIa-Miele & MukheIjee 1987). Incubation of p5 
extracts with labelled Progesterone Response Element (PRE) would help determine 
whether p105 and p70 are the rabbit progesterone receptor. 
5.2. Materials & Methods. 
5.2.1. Nuclear extracts. 
Endometrial nuclear protein extracts were provided by Chris Molloy and Phillip Daniel, 
Lincoln University. 
a) Hormone treatments. 6 New Zealand white virgin female rabbits (approx. 3.5kg) 
were injected sub-cutaneously for 5 days with 3mg progesterone per kg rabbit. 
Progesterone was supplied by Sigma and dissolved in Healtheries cold-pressed sesame 
oil. 10 New Zealand white virgin female rabbits were not treated with hormones and the 
extract (-H extract I), which does not contain UGPB, was used as a negative control. 
b) Extraction. Nuclear proteins were isolated from the endometrium according to the 
protocol described in Appendix 6. From the progesterone treated (P5) rabbits, a crude 
extract (pS crude extract I) and an extract containing UGPB after heparin-agarose (HAG) 
purification (HAG purified p5 extract I) were used. 
5.2.2. Electrophoresis. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was carried out in a Bio-Rad 
Mini-Protean IT electrophoresis unit as in Appendix 1. 0.625t.Lg Bio-Rad SDS-PAGE 
Molecular Weight Standards (High Range Specificity) was always included. 
5.2.3. Electroblotting. 
After separation, proteins were transferred from the polyacrylamide gel to Millipore 
Immobilon-P Transfer Membrane by electroblotting as in Appendix 2. After transfer, the 
region of membrane containing the molecular weight markers was excised and stained 
with amido black as in Appendix 3 for calculation of the molecular weight of proteins 
revealed by Southwestern blotting and to gauge the efficiency of transfer. 
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5.2.4. Probes. 
The -194/+9 (UG200) region of the uteroglobin promoter was labelled with [a-32P]dCfP 
provided by Amersham as described in Appendix 7. Several other probes were used, as 
detailed below, all of which were labelled with [a-32P]dCTP provided by Amersham. 
The mouse mammary tumour virus Progesterone Response Element was provided by 
Malcom Handel (Garvan Institute of Medical Research) and labelled as in Appendix 7. 
Ssp I cleaved UG200 was obtained by incubation of 12ng double end labelled UG200 
with 2.5U Ssp I at 37 0 C for 3 hours, with an additional 2.5U Ssp I added at 1 hour 
intervals. Ssp I was heat inactivated by incubation at 65 0 C for 20 minutes and cleavage 
confirmed by resolving uncut and cut UG200 samples on an 8% polyacrylamide gel. 
PCR amplification of fragments of the DNase I footprint region (-170/-85) was carried 
out using various combinations of the following primers: 
Coding strand: 1 (-170/-153) 2 (-154/-137) 3(-117/-100) 
Non-coding strand: 4 (-102/-85) 5 (-117/-100) 6(-135/-118) 
PCR amplification was occurred on a Hybaid Thermal Reactor with reagents from a 
Perkin Elmer Cetus Gene Amp DNA Amplification Reagent Kit. Final PCR reaction mix 
contained 2pg UG200 as template, 1J,LM each of two primers, 6J,LM dTfP, dATP, dCfP 
and IU AmpliTaq in a final volume of 10J,LL 1 * PCR buffer overlaid with 15J,LL mineral 
oil. The amount of 32pdCfP added depended on the primers used in an attempt to 
standardise the amount of 32pdCfP incorporated into each fragment at 2 moles 32pdCfP 
per mole of product. Cold dCfP was added to make final dCfP concentration 6J,LM. 
Volume 32pdCfP added: 1/4 1.29 J,LL; 2/4 1.57 J,LL; 3/4 3.6J,LL; 1/5 1.50J,LL; 2/63.60J,LL. 
Fragments were amplified by the following thermal regime: 1 cycle 94 0 C 1 min.; 30 
cycles 94 0 C 1 min., 48 0 C 1 min., 72 0 C 2 min.; 1 cycle 94 0 C 1 min., 48 0 C 1 min., 
72°C 10 min. 
After amplification, fragments were phenol chloroform extracted, ethanol precipitated 
and resuspended in TE [20mM Tris (pH 7.5); 1mM EDTA]. Reaction mixtures were then 
separated on a 10% polyacrylamide gel which was exposed to Kodak X-Omat AR film 
;:wernight. The position of the major fragments was marked on the gel, gel fragments 
~xcised and DNA extracted from the gel pieces by electrophoresis onto DEAE-cellulose 
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membrane as in Appendix 10. Confirmation that these fragments were the target regions 
of the uteroglobin promoter was established by Ssp I cleavage with 2.5U Ssp I at 37 0 C 
for 90 minutes, visualisation of the resulting fragments on an 8% polyacrylamide gel and 
comparison of fragment lengths with those expected. 
5.2.5. DNA· protein interactions (Gel shift assays and Southwestern blotting). 
Southwestern blotting and gel shift assays were carried out as detailed in Appendices 4 
and 8 respectively. Poly dldC was provided by Boehringer-Mannhiem. Membranes and 
dried gels were exposed to Kodak X-Om at AR film with an intensifier for 2-7 days. 
5.3. Results and Discussion. 
5.3.1. Using labelled PRE as a probe. 
Conditions for Southwestern blotting: The crudeIHAG purifiedl-H triplets were 
separated, blocked together in 5mL blocking buffer and incubated separately in 2.5mL 
binding buffer with 6ng double end labelled mouse mammary tumour virus progesterone 
response element (MMTV PRE) or 6ng double end labelled UG200 respectively. 
Plate 18. Using labelled PRE as a probe 
Protein samples. Lanes 1 & 4: 20J.Lg crude p5 extract I; 2 & 5: 20J.Lg HAG purified p5 
extract I; 3 & 6: 20J.Lg crude -H extract 1. 
Probe: Lanes 1-3: UG200; 4-6: MMTV PRE. 
53 
The intensities of the bands shown on Plate 18 are very weak. However, one protein in 
lane 4 (crude p5 extract) binds MMTV PRE and has a molecular weight of 128kDa. By 
contrast, the protein that binds UG200 in lane 2 (HAG purified p5 extract) has a 
molecular weight of 115kDa (p105). There is a band present in lane 1 (crude p5 extract) 
that binds UG200 that has a molecular weight of approximately 128kDa. From previous 
Southwestern blots using this extract, this is likely to be the 115kDa protein identified by 
Rider & Peterson (1991) as part of the UGPB complex, but which does not co-purify with 
UGPB during HAG purification (see Chapter 3). This suggests the 115kDa protein 
identified by Rider & Peterson (1991) may be the progesterone receptor, although the 
indeterminate nature of this membrane makes this conclusion questionable. However, 
Plate 18 does establish that the protein in crude p5 extract that recognises the MMTV 
PRE is not present in HAG purified p5 extract and does not co-migrate with p105 or p70. 
5.3.2. Ssp I cleavage of UG200. 
Conditions for Southwestern blotting: As in 5.3.1, but crude/HAG/-H triplets incubated 
separately with ImL binding buffer containing 12ng double end labelled UG200 or 12ng 
Ssp I cleaved double end labelled UG200 respectively. 
Plate 19. Ssp I cleavage of UG200 
Protein samples. Lanes 1 & 4: 20Slg crude p5 extract I; 2 & 5: 20Slg HAG purified p5 
extract I; 3 & 6: 20Slg crude -H extract I. 
Probe: Lanes 1-3: UG200; 4-6: Ssp I cleaved UG200. 
54 
Resolving samples of Ssp I cut and uncut UG200 on an 8% polyacrylamide gel revealed 
that Ssp I cleavage was extensive, but not complete (results not shown). A gel shift assay 
with the Ssp I cleaved UG200 sample showed a slight shift, approximately 20 fold less 
intense than the shift produced by the same amount of uncleaved UG200 (results not 
shown). Although the Ssp I cleavage of UG200 was incomplete, comparison of lanes 2 
and 5 of plate 19 show that it significantly decreases binding by p105 and p70. Again, 
p105 and p70 are displaying similar binding characteristics to UGPB, suggesting both are 
involved in the UGPB complex. 
Interestingly, comparison of the crude extract lanes (1 and 4) show that Ssp I cleavage 
also reduces binding of p 180, the 115kDa protein identified by Rider & Peterson (1991) 
and minor proteins at 82kDa, 68 kDa and 35kDa. Binding by the low molecular weight 
protein is also diminished. This suggests that they are all binding near position -130, so 
are binding within the UGPB footprint region (-170/-85). As similar proteins are also 
sometimes detected in HAG purified p5 extract I, it is possible that these minor proteins 
are precursors or derivatrives of p105 and p70, or are distinct proteins involved in the 
UGPB complex. Further investigations using different fragments of the promoter were 
undertaken to identify exactly where these proteins were binding to. 
5.3.3. Fragments of the uteroglobin promoter. 
a) 114 (-170/-85), 115 (-170/-100). 
i) Gel shift assay 
Conditions for gel shift assay: Protein samples were incubated at 100mM KCl with 1 ttL 
promoter fragment or 0.6ng UG200. One HAG purified p5 extract I reaction mix for each 
probe included with 12ng unlabelled UG200. 
1/4: -170 ------------------------------------------ -85 
1/5: -170 ---------------------------------- -100 
Prot)l' U(.i ?CO 
Ul~ PB _ 
Shdl 
Free 
Probe -
1/4 1/5 
6. 7 
Plate 20. Uteroglobin promoter fragments I: Gel shift assay 
Protein samples. Lanes 1,4 & 7: 20J,Lg crude -H extract I; 2,3,5,6,8 & 9: 20J,Lg HAG 
purified p5 extract I. 
Probes. Lanes 1-3: UG200; 4-6: 1/4; 7-9: 1/5. 
Competitors. Lanes 1,2,4,5, 7 & 8: None; Lanes 3, 6 & 9: 12ng unlabeled UG200 (20 
fold excess). 
Plate 20 demonstrates that UGPB is able to bind 1/4 (lane 5). However, the absence of 
free probe or UGPB shift in lanes 7-9, incubated with 1/5, suggests a mistake in the gel 
shift assay procedure, as the Southwestern blot (see below) shows that labelled 1/5 was 
present in this sample. 
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ii) Southwestern blot 
Conditions for Southwestern blotting: The crude/HAG/-H triplets were separated, 
blocked together in 5mL blocking buffer and incubated separately in 1mL binding buffer 
containing 12ng double end labelled UG200 or 20t,LL purified promoter fragment. 
1/4: -170 ------------------------------------------ -85 
1/5: -170 ---------------------------------- -100 
Plate 21. Uteroglobin promoter fragments I: Southwestern blot 
Protein samples. Lanes 1,4 & 7: 20t,Lg crude p5 extract I; 2,5 & 8: 20t,Lg HAG purified 
p5 extract I; 3,6 & 9: 20t,Lg crude -H extract I. 
Probes. Lanes 1-3: UG200; Lanes 4-6: 1/4; Lanes 7-9: 1/5. 
Lane 6 of Plate 21 demonstrates that both p 1 05 and p70 are able to bind 1/4, which spans 
the UGPB DNase I footprint. Lane 8 indicates that p70 is not able to bind 1/5, which is 
missing 16bp at the end of the footprint proximal to the uteroglobin start site. It therefore 
appears that p 105 and p70 are two distinct proteins that bind different regions of the 
uteroglobin promoter. Several other proteins in crude p5 extract I are also able to bind 
both 1/4 and 1/5, with molecular weights 170kDa, 116kDa, 79kDa, 68kDa and 16kDa 
(lanes 4 and 7). As discussed above, this suggests that these are not non-specific DNA-
binding proteins, but may be proteins related to p 1 05 and p70, or distinct proteins also 
involved in the UGPB complex. This experiment was repeated with an additional 
fragment in order to extend information about the binding site of these proteins. 
b) 1/4 (-170/-85),3/4 (-117/-85) & 1/5 (-170/-100). 
i) Gel shift assay 
Protein samples: HAG purified p5 extract I. 
Conditions for gel shift assay: Each protein sample incubated at l00mM KCI with 1 J.LL 
promoter fragment or 0.6ng double end labelled UG200 and competitors as outlined 
below. 
1/4: -170 ------------------------------------------ -85 
3/4: -117 ---------------- -85 
1/5: -170 ---------------------------------- -100 
Probe 
UGPB -
Shlfl 
Free _ 
Probe 
UG200 1/5 
Plate 22. Uteroglobin promoter fragments II: Gel shift assay 
3/4 
10 11 12 
••• 
Protein samples. Lanes 1,4, 7 & 10: OJ.Lg protein; 2, 3, 5, 6, 8,9, 11 & 12: 20J.Lg HAG 
purified p5 extract I. 
Probes. Lanes 1-3: UG200; 4-6: 1/4; 7-9: 1/5; 10-12: 3/4 
Competitors. Lanes 1,2,4,5,7,8,10,11: None; Lanes 3, 6,9 & 12: 12ng unlabeled 
UG200 (20 fold excess). 
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Plate 22 indicates that both 1/4 and 1/5 are able to bind UGPB (lanes 5 & 8), whereas 3/4 
(lane 11) is not. The 
-170/-118 region (the region of the DNase I footprint that 3/4 does not contain) therefore 
appears to be vital for UGPB binding. The intensities of the shifts suggest that 1/5 binds 
UGPB more strongly than 1/4 (lane 5 cf. lane 8), but the probes did not have equal 
specific activities. When probes with equal specific activity are used, 1/5 produces a less 
intense shift than 1/4, so the -100/-85 region although not essential, does also playa role 
in UGPB binding (C. Molloy, personal communication). 
ii) Southwestern blot - HAG purified p5 extract. 
Conditions for Southwestern blotting: Membranes were blocked in 5mL blocking buffer. 
Sections were incubated separately in 1mL binding buffer containing 6ng double end 
labelled UG200 or lOJ.LL promoter fragments respectively. 
1/4 -170 ------------------------------------------ -85 
3/4: -117 --------------- -85 
1/5: -170 ---------------------------------- -100 
, 
J 
Probe. UG200 1/ 4 3/4 115 
kOa 3 4 
n 
71 
211 
25 
19 
Plate 23. Uteroglobin promoter fragments II: Southwestern blot 
Protein samples. Lanes 1-4: 30 J.Lg HAG purified p5 extract 1. 
Probes. Lane 1: UG200; 2: 1/4; 2: 3/4; 4: 1/5. 
Although band intensities are faint, Plate 23 confinns that both p105 and p70 bind to 1/4 
(lane 2). Lane 3 shows that p70 is able to bind to 3/4, but the presence of p 105 in lane 3 is 
difficult to detennine due to smudging. Close examination suggests pl05 is absent. Lane 
4 demonstrates that p 105 is able to bind 1/5, whereas p70 appears to be unable to. In 
summary, p105 and p70 bind to distinct regions of the uteroglobin promoter. p105 binds 
upstream and requires the -170/-117 region (absent in 3/4) for binding, whereas p70 binds 
downstream and requires the -110/-85 (absent in 1/5) for binding, as shown in Figure 4. 
This is also important evidence that p70 is not a cleavage product of p 105. However, 
smudging and the low specific activities of probe makes such an interpretation 
questionable, so the experiment was repeated. 
pl05 p70 
1-------------------------11-------------1 
-170 ------------------------------------------ -85 
T Ssp I cleavage site 
Figure 4. Model for pl05 and p70 binding to the uteroglobin promoter. 
c) 114 (-170/-85),2/4 (-154/-85),3/4 (-1171-85) & 1/5 (-170/-100). 
i) Gel shift assay 
Conditions for gel shift assay: Samples incubated at 100mM KCI with 1 ilL promoter 
fragment or 0.6ng double end labelled UG200. 
UGPB -
Shift 
Free 
P.obe 
1/4: -170 ------------------------------------------ -85 
2/4: -154 ---------------------------------- -85 
3/4: -117 ---------------- -85 
1/5: -170 ---------------------------------- -100 
UG200 1/4 2/4 I· I 
. . 10 
0,. 
11 12 
'--
Plate 24. Uteroglobin promoter fragments HI: Gel shift assay 
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1/5 
Protein samples. Lanes 1,3,6,9 & 12: OJ,Lg protein; 2,4,7, 10 & 13: 20J,Lg HAG purified 
p5 extract I; 5, 8, 11, & 14: 40J,Lg HAG purified p5 extract I. 
Probes. Lanes 1 & 2: UG2oo; 3-5: 1/4; 6-8: 2/4; 9-11: 3/4; 12-15: 1/5. 
Plate 24 confinns that the -154/-118 region is critical for UGPB binding, as 3/4, the only 
fragment that lacks this region, does not bind UGPB (lane 11), whereas 1/4,2/4 and 1/5 
do bind UGPB (lanes 5, 8 and 14). The appearance of other minor shifts in these lanes 
suggests the presence of low affinity UG200 binding proteins that may not be visible in 
other lanes because most of the probe is being bound by UGPB. 
ii) Southwestern blot - HAG purified p5 extract. 
Conditions for Southwestern blotting: The membrane was blocked in 4mL blocking 
buffer. Sections were separated and the crudeIHAG pair was incubated in 1.5mL binding 
buffer with 6ng double end labelled UG2oo, while each remaining lane was incubated in 
1.5mL binding buffer with lOJ,LL of one promoter fragment. 
1/4: -170 ------------------------------------------ -85 
2/4: -154 ---------------------------------- -85 
3/4: -117 --------------- -85 
1/5: -170 ---------------------------------- -100 
Plate 25. Uteroglobin promoter fragments In: Southwestern blot, HAG purified 
extract 
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Protein samples. Lane 1: 50t,Lg crude p5 extract II; 2-6: 50t,Lg HAG purified p5 extract I. 
Probes. Lanes 1 & 2: UG200; 3: 1/4; 4: 2/4; 4: 3/4; 5: 1/5. 
Plate 25 demonstrates that p 105 is able to bind 2/4 (lane 4) as well as 1/4 and 1/5 (lanes 3 
& 6), so p105 must be bind to the -154/-100 region (the region these three probes share). 
However, lane 5 appears to indicate that pI 05 is also able to bind 3/4, although close 
examination of the autoradiograph suggests thisis a smudge rather than the p 105 band. 
Lanes 13-14 of Plate 24 demonstrated that the 3/4 probe had a similar specific activity to 
the other probes used. If the mark in lane 5 is assumed to be p105, it appears to be 
binding 3/4 with much lower intensity than the other fragments, confirming that the 
-154/-118 region (absent in 3/4) is important for pI 05 binding. Plate 24 demonstrates that 
the -154/-118 region is also essential for UGPB binding in the gel shift assay. 
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The simplest explanation of these results is that pi 05 binding is synonymous with UGPB 
binding, whereas p70, which Plate 23 indicates is able to bind to 3/4, is not. Yet this does 
not necessarily exclude p70 from playing a role in the UGPB complex. As noted above, 
the absence of the -100/-85 region, which is necessary for p70 binding, reduces the 
intensity of the UGPB shift (c. Molloy, personal communication). p70 may therefore 
playa role in stabilising the UGPB complex, but is not necessary for UGPB binding. 
However, the possibility that p105 is able to bind 3/4 and the absence of a p70 band in 
lanes 4-6 means that no definitive conclusions about the binding sites of pi 05 and p70 are 
able to be drawn and the model proposed in Figure 4 cannot be confirmed. It is 
interesting to note that proteins at 170kDa (probably p180), 140kDa and 28kDa are all 
able to bind 1/4 (lane 3). These proteins may therefore also playa role in the UGPB 
complex, or may be responsible for minor shifts sometimes observed in gel shift assays. 
iii) Southwestern blot - crude p5 extract. 
Protein samples: HAG purified p5 extract I and crude p5 extract II (see Chapter 7). 
Conditions for Southwestern blot: As for HAG purified p5 extract. 
1/4: -170 ------------------------------------------ -85 
2/4: -154 ---------------------------------- -85 
3/4: -117 ---------------- -85 
1/5: -170 ---------------------------------- -100 
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Plate 26. Uteroglobin promoter fragments Ill: Southwestern blot, crude extract 
Protein samples. Lane 1: 50J,Lg HAG purified p5 extract I; 2-6: 50J,Lg crude p5 extract II. 
Probes. Lanes 1 & 2: UG200; 3: 1/4; 4: 2/4; 4: 3/4; 5: 1/5. 
Unfortunately it is difficult to detennine the presence of p 105 in lane 5 of Plate 26 due to 
the intensity of the 122kDa band. This 122kDa protein is likely to be the Rider & 
Peterson (1991) 115kDa protein (see Chapter 3) and is able to bind all fragments of the 
uteroglobin promoter used (lanes 2-5). Because the gel shift assay shown in Plate 25 was 
carried out with HAG purified p5 extract, which does not contain the 115kDa protein, 
there is no way of knowing whether the 115kDa protein can elicit a shift with 3/4. The 
fact that this protein is not co-purified with UGPB (Chapter 3) suggests it is not a 
precursor of p105 and p70 or a distinct protein involved in the UGPB complex and may 
be a non-specific DNA-binding protein such as a histone. Of the other proteins that are 
able to bind all four fragments, those migrating at 175kDa, 145kDa, 61kDa and 40kDa 
have similar molecular weights to proteins occasionally visible in HAG purified extract 
(eg Plates 1 & 12), so may be proteins involved in the UGPB complex. 
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5.4. Conclusions 
Despite the similarity in molecular weight between p 105 and p70 and the rabbit 
progesterone receptor, these proteins are unable to bind to the mouse mammary tumour 
virus progesterone response element, whereas the 115kDa protein identified by Rider & 
Peterson (1991) may be able to. Previous chapters have suggested that both pl05 and p70 
are involved in the UGPB complex. The fact that Ssp I cleavage of UG200 reduces 
binding of both proteins to UG200 and that both proteins bind to the -175/-85 DNase I 
footprint region is also strong supporting evidence that these two proteins are involved in 
UGPB. p105 and p70 may bind to distinct sites within the footprint region, with p105 
binding distally and p70 binding proximally to the utero globin start site. Other minor 
proteins in HAG purified p5 extract (170kDa, 140kDa, 28kDa) are also able to bind to 
the UGPB footprint region, so may also be involved in the UGPB complex. 
There are also several proteins in crude p5 extract able to bind to fragments of the 
uteroglobin promoter. Some of these may be non-specific DNA-binding proteins not 
involved in the UGPB complex. In particular, the 115kDa protein identified by Rider & 
Peterson (1991) that is not co-purified with UGPB binds all fragments of the uteroglobin 
promoter tested. Some other proteins that bind uteroglobin promoter fragments in crude 
p5 extract are sometimes detected in HAG purified p5 extract, so a role for these proteins 
in the UGPB complex cannot be eliminated. 
CHAPTER 6 - EXTRACTION OF UGPB FROM THE GEL SHIFT 
Can plOS/p70 be extracted from the UGPB shift? 
6.1. Introduction. 
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Chapters 2-5 provide extensive evidence correlating pI05 and p70 with UGPB in tenns 
of their binding activity, purification, specificity and binding site. However, all this 
evidence is indirect; that is, attempting to establish p 105 and p70 as components of 
UGPB by comparing characteristics of UGPB with characteristics of p 105 and p70. One 
method to confirm whether p105 and/or p70 are involved in the UGPB shift is to purify 
UGPB and examine the DNA binding activity of its individual component(s). Efforts to 
purify UGPB are continuing at Lincoln University. Alternatively, as UGPB is defined as 
the protein complex causing a specific band in the gel shift assay, if the proteins present 
in the shift region can be extracted from the gel shift assay polyacrylamide gel, their 
molecular weight and DNA binding activity could be investigated. If successful, this 
approach would provide a direct link between proteins that bind UG200 identified by 
Southwestern blotting and the UGPB complex identified by gel shift assay. Two 
approaches were used to extract the UGPB complex from a gel shift assay, elution and 
electro-extraction. 
6.2. Materials & Methods. 
6.2.1. Nuclear extracts. 
Endometrial nuclear protein extracts were provided by Chris Molloy, Lincoln University. 
a) Hormone treatments. 6 New Zealand white virgin female rabbits (approx. 3.5kg) 
were injected sub-cutaneously for 5 days with 3mg progesterone per kg rabbit. 
Progesterone was supplied by Sigma and dissolved in Healtheries cold-pressed sesame 
oil. 
b) Extraction. Nuclear proteins were isolated from the endometrium according to the 
protocol described in Appendix 6. A Heparin-agarose purified sample (HAG purified p5 
extract I) known to contain UGPB was used. 
6.2.2. Electrophoresis. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was carried out in a Bio-Rad 
Mini-Protean II electrophoresis unit as in Appendix 1. O.625tLg Bio-Rad SDS-PAGE 
Molecular Weight Standards (High Range Specificity) was always included. 
6.2.3. Probes. 
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The -194/+9 (UG200) region of the uteroglobin promoter was labelled with [a-32P]dCfP 
provided by Amersham as described in Appendix 7. 
6.2.4. DNA-protein interactions (Gel shift assays and Southwestern blotting). 
Gel shift assays were carried out as in Appendix 8. Poly dIdC was provided by 
Boehringer-Mannhiem. Dried gels were exposed to Kodak: X-Om at AR film with an 
intensifier for 2-7 days. 
6.3. Results and Discussion. 
6.3.1. Elution of the UGPB shift. 
a) Elution I. 
Conditions for gel shift assay: 7 lanes of 12.3 tLg HAG purified p5 extract I (total 86.1 tLg) 
were each incubated with O.6ng double end labelled UG200 at l00mM KCI, while 
another 7 lanes were incubated at l00mM KCI without double end labelled UG200 in the 
incubation mix, to act as a negative control. 
Conditions for elution: Proteins were eluted from the shift as in Appendix 12, separated 
on a polyacrylamide gel along with molecular weight markers and HAG purified p5 
extract I as in Appendix 1. The gel was silver stained as in Appendix 11. 
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Plate 27. Elution of the UGPB shift I 
Protein samples. Lanes 1 & 6: 20J,Lg HAG purified p5 extract I; 2 & 4: O.625J,Lg molecular 
weight markers; 3: gel shift eluate; 4: negative control eluate. 
Plate 27 shows 4 proteins common to the eluates from both the negative control region 
and the shift region of the gel, one negatively staining and three positively staining (lanes 
3 and 4). Their presence in both eluates suggests that these proteins move to this position 
in the gel because of their inherent negative charge (the gel-shift assay is carried out in 
non-denaturing conditions), rather than interaction with labelled DNA. They therefore 
have no role in the UGPB complex. The other interesting feature of the gel is the protein 
with molecular weight 66kDa present only in the negative control eluate (lane 4). It is 
surprising that this protein is not present in the shift region eluate, since both eluates 
come from the same HAG purified p5 fraction and were electrophoresed in the same gel. 
One possibility is that excision of the negative control lanes did not occur at exactly the 
same position as the shift excision and a region of gel containing an additional protein 
was included. Alternatively, it is possible that the samples became switched during the 
elution procedure and this 66kDa protein is actually present in the shift complex. Due to 
the indeterminate nature of the results, the experiment was repeated. 
b) Elution H. 
Conditions for gel shift assay: As in 6.3.1.a. 
Conditions for elution: As in 6.3.1.a., but gel pieces eluted in 2mL elution buffer. 
Plate 28. Elution of the UGPB shift n 
Protein samples. Lane 1: 20J,.Lg HAG purified p5 extract I; 2 & 4: O.625J,.Lg molecular 
weight markers; 3: gel shift eluate; 5: negative control eluate. 
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Plate 28 shows two bands common to both eluates, at approximately 66kDa and 50kDa 
(lanes 3 and 5). The diffuse low molecular weight band in the shift region eluate (lane 3) 
was radioactive, so is likely to be double end labelled UG200 eluted from the shift. Plates 
27 and 28 show different patterns of proteins. This may be because a slightly different 
region of gel was excised in the two experiments. However, it also possible that overnight 
shaking in elution buffer at 37 0 C may have caused cleavage of some of the proteins. This 
means that even if proteins were identified in the shift region eluate that were not present 
in the negative control eluate, they may not accurately represent the proteins involved in 
the UGPB complex. Because of this, an alternative approach was used to minimise 
disturbance of proteins, electrophoretic extraction, where proteins were extracted from 
the gel shift assay by electrophoresis into an SDS polyacrylamide gel. 
6.3.2. Electrophoretic extraction of the UGPB shift. 
Protein samples: As in 6.3. La. 
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Electrophoretic extraction: Gel fragments were excised and placed on to a 5% 
polyacrylamide stacking gel on a 10% polyacrylamide resolving gel as in Appendix 1 and 
cemented in place with additional 5% polyacrylamide gel. The gel was electrophoresed, 
with molecular weight markers and silver stained as in Appendix 11. 
kDa 
200 -
116 -
98 -
66 -
43-
2 
Plate 29. Electrophoretic extraction of the UGPB shift 
3 
Protein samples. Lane 1: UGPB shift eluate; 2: 0.625/lg molecular weight markers; 3: 
negative control eluate. 
Plate 29 shows no distinct protein bands extracted either from the shift region or the 
negative control region of the gel shift assay (lanes 1 and 3). The presence of high 
molecular weight streaks suggests that proteins were being continually extracted from 
both regions during electrophoresis and were therefore unable to resolve into discrete 
bands. Placing the gel shift assay gel fragments into the SDS polyacrylamide gel resulted 
in twisting and packing of the gel fragments, which may have impeded extraction by 
electrophoresis. 
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6.4. Conclusions. 
Two approaches were used to extract UGPB from the shift region of a gel shift assay, 
elution and electrophoresis. Elution identified several proteins present in this region of 
the gel, but none were present specifcally in the shift region. Extraction by 
electrophoresis did not identify any proteins. Extraction of UGPB from the gel shift or 
purification of UGPB remains a critical link in establishing the role of p70 and pI 05 in 
the UGPB complex. Since Southwestern blotting identifies many proteins able to bind 
UG200, it is important to determine which have an active role in the UGPB complex. 
Electroelution (electrophoretic extraction of proteins from polyacrylamide gel into a 
surrounding buffer), may be applicable to this case (Stearne et. al. 1985). It is important 
to note however, that most researchers using Southwestern blotting do not attempt to 
establish this connection and assume that proteins binding labelled DNA after 
Southwestern blotting are the same as those identified by gel shift assay. 
CHAPTER 7 - DISTRIBUTION 
Are pH\~/!>70 expressed in the same tissues and 
under the same hormone influence as UGPB? 
7.1. Introduction. 
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Until recently, the presence of UOPB in nuclear extract was defined by the presence of a 
particular band in a gel shift assay. Rider & Bullock (1988) used such a definition to 
suggest that UOPB is specific to progesterone-dominated endometrium and to speculate 
that there is an inhibitor of UOPB in progesterone-dominated liver and lung extracts, 
because mixing these fractions with a crude p5 endometrial fraction abolished the UOPB 
shift. However, Phillip Daniel of Lincoln University established that the inhibitory 
activity of such extracts is caused by the presence of DNA extracted with the nuclear 
proteins (P. Daniel, personal communication). Removal of DNA from extracts by DEAE 
fractionation can reveal the presence of the UOPB shift. Using this approach, P. Daniel 
identified UOPB in oestrogen stimulated endometrium, but not in unstimulated 
endometrium. 
This result has important implications for the role of UOPB in the regulation of the 
uteroglobin gene, as oestrogen treatment alone does not stimulate uteroglobin expression. 
It could also be speculated that UOPB could be present in tissues such as the lung where 
uteroglobin is also expressed, but in which UOPB was not able to be detected by gel shift 
assay. Further experiments are necessary to establish exactly in which tissues and under 
which hormone treatments UOPB can be detected. DEAE fractionating all extracts to 
remove DNA is one approach. However, the SDS-PAOE step of the Southwestern 
blotting procedure would also separate nuclear proteins from contaminating DNA in 
crude extracts, in this case by electrophoresis. If it is assumed that p 105 and p70 are 
involved in the UOPB complex, for which this dissertation provides evidence, then 
Southwestern blotting would be informative as to the presence of UOPB in these extracts. 
This approach may also provide information about the identity of other bands visible in 
crude p5 endometrial extract. If such proteins are detected in all tissues, there would be 
strong evidence that they are non-specific DNA binding proteins such as histones or 
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topoisomerases. For these two reasons, to infer whether the additional proteins identified 
by Southwestern blotting are non-specific DNA binding proteins and to establish the 
presence of UGPB in other extracts, Southwestern blotting was applied to nuclear protein 
samples taken from various organs of progesterone stimulated, oestrogen stimulated and 
unstimulated rabbits. 
7.2. Materials & Methods. 
7.2.1. Nuclear extracts. 
a) Hormone treatments. 
Progesterone and I3-Estradiol 3-Benzoate were provided by Sigma and suspended in 
Healtheries cold-pressed sesame oil. 
i) Progesterone stimulated rabbits: 8 NZ white virgin female rabbits (approx. 3.5 kg.) 
were injected sub-cutaneously with 3mg progesterone per kg rabbit (rabbits 3 - 4.5kg) 
every 24 hours for 5 days and were killed on Day 6, approximately 24 hours after the last 
injection. 
ii) Oestrogen stimulated rabbits: 5 NZ white virgin female rabbits (approx. 3.5 kg.) were 
injected sub-cutaneously with 50J,Lg l3-oestradiol-3-benzoate every 24 hours for 5 days 
and were killed on Day 6, approximately 24 hours after the last injection. 
ii) Unstimulated rabbits: 7 NZ white virgin female rabbits (approx. 3.5 kg.) were killed 
after enclosure in the same conditions as the rabbits above. 
b) Extraction. A total of 25g of liver, kidney, lung and intestine samples were taken 
from each group. Spleen, ovaries and endometrial samples were pooled from all members 
of each group. Nuclei were extracted from each sample as in Appendix 6. Intestinal 
contents were flushed with 0.9% saline before extraction. These extracts are hereafter 
referred to as p5 extract II, E5 extract and -H extract II respectively. A HAG purified 
endometrial nuclear protein extract (P5 extract I), described previously and provided by 
Chris Molloy, Lincoln University was used as a positive control. 
7.2.2. Electrophoresis. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was carried out in a Bio-Rad 
Mini-Protean II electrophoresis unit as in Appendix 1. 0.625J,Lg Bio-Rad SDS-PAGE 
Molecular Weight Standards (High Range Specificity) was always included. 
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7.2.3. Electroblotting. 
After separation, proteins were transferred from the polyacrylamide gel to Millipore 
Immobilon-P Transfer Membrane by electroblotting as in Appendix 2. After transfer, the 
region of membrane containing the molecular weight markers was excised and stained 
with amido black as in Appendix 3 for calculation of the molecular weight of proteins 
revealed by Southwestern blotting and to gauge the efficiency of transfer. 
7.2.4. Probes. 
The -194/+9 (UG200) region of the uteroglobin promoter was labelled with [a-32P]dCfP 
provided by Amersham as described in Appendix 7. 
7.2.5. DNA-protein interactions (Gel shift assays and Southwestern blotting). 
Southwestern blotting and gel shift assays were carried out as detailed in Appendices 4 
and 8 respectively, except that protein samples were incubated in 1 % SDS sample buffer 
before SDS-PAGE to avoid formation of an insoluble SDS-KCl complex that occurs at 
high KCI concentrations. Poly dldC was provided by Boehringer-Mannhiem. Membranes 
and dried gels were exposed to Kodak X-Om at AR film with an intensifier for 2-7 days. 
7.3. Results and Discussion. 
7.3.1. Gel shift assay. 
Conditions for gel shift assay: All samples were incubated at 340mM KCl. 
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Plate 30. UGPB distribution: Gel shift assay (endometrium, lung, ovary and kidney 
extracts) 
Protein samples. Lane 1: OJ,J.g protein; 2: 20J,J.g HAG purified p5 extract J; 3-5: 20J,J.g 
endometrial extract (progesterone- dominated (P), oestrogen-dominated (E) and 
unstimulated (-) tissue respectively); 6-8: 20J,J.g lung extract (P, E and - tissue 
respectively); 9-11: 20J,J.g ovary extract (P, E and - tissue respectively); 12-14: 20J,J.g 
kidney extract (P, E and - tissue respectively). 
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Plate 31. UGPB distribution: Gel shift assay (spleen, liver and intestine extracts) 
Protein samples. Lane 1: OJ..l.g protein; 2: 20J..l.g HAG purified p5 extract I; 3-5: 20J..l.g 
spleen extract (P, E and - tissue respectively); 6-8: 20J..l.g liver extract (P, E and - tissue 
respectively); 9-11: 20 J..l.g intestine extract (P, E and - tissue respectively). 
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Plates 30 and 31 indicate that only progesterone-dominated endometrium (Lane 3, Plate 
30) contains UGPB. This result conforms with previous observations that UGPB cannot 
be detected by gel shift assay in kidney and lung extracts (Rider & Bullock 1988). 
However as noted above, the presence or absence of a shift is not necessarily indicative of 
the presence of UGPB, as contaminating DNA may be inhibiting the formation of the 
UGPB complex. Consequently the presence of p105 and p70 in the Southwestern blots 
may be a better indication of the presence of UGPB. 
Several fractions in Plate 30 display minor shifts, particularly endometrial fractions 
(Lanes 3-5), lung fractions (6-8) and ovary fractions (9-11). These shifts are also 
irregularly observed in progesterone-dominated endometrium and are not competed 
strongly by UG200 (c. Molloy, personal communication). They may be the result of 
UG200 binding a subset of proteins involved in the UGPB complex, cleavage products of 
UGPB components, or non-specific DNA binding proteins that are not completely 
eliminated by dldC. With prolonged exposure (2 weeks), all endometrial extracts, 
oestrogen-dominated ovary and lung and oestrogen-dominated and unstimulated spleen 
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could all be interpreted as containing a UGPB shift, although this is probably the result of 
interference from these minor shifts (results not shown). 
7.3.2. Southwestern blots. 
Conditions for Southwestern blotting: Membranes were blocked in 5mL blocking buffer 
and incubated with 24ng double end labelled UG200 in 2.5mL binding buffer. 
Plate 32. UGPB distribution: Southwestern blot (endometrium and lung extracts) 
Protein samples. Lane 1: 20J.,Lg HAG purified p5 extract I; 
2-4: 50 J.,Lg endometrial extract (progesterone- dominated (P), oestrogen-dominated (E) 
and unstimulated (-) tissue respectively); 6-8: 50J.,Lg lung extract (P, E and - tissue 
respectively). All samples were made 340mM KCl. 
Plate 33. UGPB distribution: Southwestern blot (ovary and kidney extracts) 
Protein samples. Lane 1: 20J,Lg HAG purified p5 extract I; 
2-4: 50J,Lg ovary extract (P, E and - tissue respectively); 
6-8: 50J,Lg lung extract (P, E and - tissue respectively). All samples were made 340mM 
KCl. 
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Plate 32 demonstrates that a protein that co-migrates with p 105 is present in all 
endometrial extracts regardless of honnone status (lanes 2-4). A protein that co-migrates 
with p70 is also present in progesterone-dominated endometrium and unstimulated 
endometrium. A similar 68kDa protein is present in oestrogen-dominated endometrium 
(lane 3). The presence of p 105 and p70 in unstimulated endometrium (Plate 33, lane 4) is 
surprising, given the consistent absence of any UG200 binding proteins in the 
unstimulated crude endometrial extract used in earlier chapters (crude -H extract I). 
However, this extract was kept in a -20· C freezer with a tendency to defrost, so binding 
activity in the extract could have been lost during storage. p105 should not be confused 
with the major band at 120kDa in lanes 2-4, which is probably the 115kDa protein 
identified by Rider & Peterson (1991) as discussed in Chapter 3. All samples were made 
340mM KCI before SDS-PAGE, so there should be no difference in protein mobility 
between the lanes. 
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p105 may also be present in all three lung samples (Plate 33, lanes 5-8) and both p105 
and p70 may be present in oestrogen-dominated ovary (Plate 34, Lane 3). Since affinity 
purification suggests strongly that p 105 is involved in the UGPB complex and the role of 
p70 in UGPB is less well established, it could be argued that UGPB is present in all lung 
samples and in oestrogen-dominated ovary, as well as all endometrial samples. However, 
the existence of so many bands in these lanes makes interpretation of which protein 
relates to p 105 and p70 relatively subjective. Separation of the fractions on larger gels 
may ease interpretation. 
Plate 34. UGPB distribution: Southwestern blot (spleen and liver extracts) 
Protein samples. Lane 1: 20J,lg HAG purified p5 extract I; 
2-4: 50J,lg spleen extract (P, E and - tissue respectively); 6-8: 50J,lg liver extract (P, E and 
- tissue respectively). All samples were made 340mM KCl. 
Plate 35. UGPB distribution: Southwestern blot (intestine extracts) 
Protein samples. Lane 1: 20llg HAG purified p5 extract I; 
2-4: 50llg intestine extract (P, E and - tissue respectively). All samples were made 
340mM KCl. 
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The number of proteins that bind UG200 in endometrial, lung and ovary samples (Plates 
32 and 33), raised questions about their role in the regulation of UG200. If these are non-
specific DNA binding proteins such as histones or topoisomerases, their absence from 
kidney, spleen, liver and intestinal extracts is unexpected (Plate 33 lanes 5-7, 34 lanes 2-
7,35 lanes 2-5). Chapter 5 establishes that several minor proteins such as these are able to 
bind to the fragments of the UGPB footprint region, so could be precursors or cleavage 
products of UGPB, or distinct proteins involved in the UGPB complex. The presence of 
so many additional proteins makes elution of UGPB from the shift region (as suggested 
in Chapter 6) a vital experiment, to attempt to establish whether any of these proteins 
have a role in UGPB binding. However, regardless of the identity of individual proteins, 
the presence of numerous UG200 binding proteins in lung, ovary and some kidney and 
spleen extracts provides more impetus to re-evaluate the distribution and role of UGPE. 
Spleen E5 extract contains two UG200 binding proteins which may relate to the minor 
shifts observed in this extract (Plate 31, lane 4). The only other major protein in spleen 
and intestinal extracts is the 17 -18kDa protein present in all extracts except liver and 
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some kidney and intestinal extracts. If this protein is a cleavage product of UGPB, the 
intensity suggests most of the UGPB in these samples has been degraded. It was 
suggested in Chapter 2 that this protein may be the endometrial specific TAT A box 
binding factor described by Misseyani et. al. (1991), but its presence in a diversity of 
tissues rules out this alternative. Chapter 5 establishes that such a protein is able to bind 
to the footprint region of UG200, so it could be a cleavage product of UGPB, or another 
protein that plays a role in the UGPB complex. A further alternative is that it is DNA that 
is hybridising to the UG200 probe. Although the Southwestern blotting conditions would 
not be expected to denature either membrane-bound DNA or the UG200 probe to allow 
hybridisation to occur, such an explanation is also a reasonable one to explain the very 
low molecular weight protein in several lanes (Plate 33 lanes 2, 3, 7 & 8; Plate 34 lane 7; 
Plate 35 lanes 2-4; Plate 36 lanes 2-3) which is co-migrating with the bromophenol blue 
dye front and therefore has a very small molecular weight. The alternative is that this 
protein has a smaller diameter than the pore size of the gel. 
7.4. Conclusions. 
Southwestern blotting has established that pI 05 and p70 and therefore by inference 
UGPB, are not restricted to progesterone-dominated endometrium as was previously 
thought. p70 and/or p105 appear to be present in endometrium regardless of hormone 
treatment and may also be present in lung and ovary extracts. In these three tissues, p 105 
and p70 are accompanied by a range of other proteins that bind UG200. Previous 
experiments suggest that at least some of these may be derivatives or precursors of pI 05 
and p70, or are distinct proteins involved in the UGPB complex. Deliniation of the exact 
role of these proteins awaits purification of UGPB. Southwestern blotting is therefore a 
valuable tool in establishing the presence of UGPB because it separates nuclear proteins 
from contaminating DNA. The evidence it provides that UGPB may be present in 
endometrial, lung and ovary extracts challenges the proposed role of UGPB as an 
endometrial-specific transcription factor that regulates uteroglobin in reponse to 
progesterone. 
CHAPTER 8 - DISCUSSION 
What has Southwestern blotting revealed about the 
composition and role of UGPB? 
8.1. Limitations of Southwestern blotting. 
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Before drawing any conclusions from the work detailed in the preceding chapters, it is important to 
note that there are intrinsic limitations in using Southwestern blotting to investigate DNA binding 
complexes. Firstly, the results of Southwestern blotting are relatively variable. For example, in 
some instances several proteins are detected in heparin-agarose purified p5 endometrial extracts (eg. 
Plate 1), whereas in other cases only p105 can be identified (eg. Plate 8). The reasons for this are not 
clear, as the protocol used was the same for all experiments. One possibility is that the efficiency of 
electroblot transfer may vary, as the length of transfer was not strictly regulated. However, amido 
black staining of molecular weight markers transferred with the protein samples was carried out in 
all experiments and in no instance did the transfer appear to be significantly impaired. In some 
cases, polyacrylamide gels were silver stained after transfer and these always indicated complete 
transfer apart from very high molecular weight proteins (>250kDa). 
The extent of protein denaturation is a more likely factor, because proteins must retain their native 
conformation for protein-DNA interaction to occur. In Chapter 3, proteins in Plate 11 were 
incubated with an equal volume of 1 % SDS sample buffer before separation on a polyacrylamide 
gel, whereas in Plate 105% SDS sample buffer was used. The fact that many more proteins were 
detected in the same nuclear extract after incubation with 1 % SDS sample buffer is evidence that 
denaturation of proteins is important. 
Regardless of the cause of variation, the variable detection of minor proteins by Southwestern 
blotting is a significant limitation. Several experiments used the presence or absence of proteins as 
evidence for the behaviour of these proteins, such as experiments in Chapter 5 using different 
fragments of the uteroglobin promoter as probes. Although this may be a reasonable approach for 
p105 which consistently gives a strong band, it is less reasonable for proteins such as p70 which are 
not always as readily detected. 
82 
Most significantly, using Southwestern blotting to analyse transcription factors is limited because it 
involves separation of the components of a DNA binding complex. In a recent review, Frankel & 
Kim (1991) pointed out that transcription factors probably often act as complexes held together by 
many protein-protein and protein-DNA interactions. A transcription factor complex therefore 
involves a number of factors that may interact with low affinity or specificity for the DNA target 
site by themselves. The gel shift assay provides a binding environment wherein such protein-protein 
interactions can take place, as the nuclear extract and probe are incubated in a small volume in non-
denaturing conditions. However, by separating nuclear proteins by SDS-PAGE, Southwestern 
blotting is unable to detect proteins that are involved in a transcription factor complex, but which 
bind with low specificity by themselves. Obviously Southwestern blotting will also not detect 
proteins regulating protein-protein interactions within the complex that do not bind DNA directly. 
Southwestern blotting is therefore inherently limited in defining the composition of transcription 
factor complexes. 
8.2. Are piOS and p70 components of UGPB? 
p 105 and p70 are the two major UG200 binding proteins proteins detected in heparin-agarose 
purified progesterone-dominated endometrial extract by Southwestern blotting. p105 is probably the 
94kDa protein identified by Rider & Peterson (1991), while the 115kDa protein identified by them 
is not co-purified with UGPB. However, a direct correlation between p105 and the proteins 
identified by Rider & Peterson (1991) is not possible, as Chapter 2 established that a component of 
the protocol used by Rider & Peterson (1991) was causing dissociation of protein-UG200 
complexes. The results stated by Rider & Peterson (1991) were therefore not able to be repeated. 
Southwestern blotting has provided evidence for the involvement of both p 105 and p70 in the 
UGPB complex. Both p105 and p70 have a higher affinity for UG200 at low Mg++ concentrations, 
bind UG200 in TGEM 100/5, bind to the UGPB footprint region and are heparin-agarose purified 
with UGPB. The strongest evidence is that affinity purification of UGPB leads to significant 
purification and concentration of p 105. p 105 and p70 bind to different regions of the uteroglobin 
promoter and bind UG200 with different specificities, so are functionally distinct proteins. Attempts 
made to directly extract proteins from the UGPB shift were unsuccessful, so confmnation of the 
role of pI 05 and p70 in the UGPB complex will require purification of UGPB or electroelution of 
the shift complex from a gel shift assay gel. However, Southwestern blotting has established p 105 
and to a lesser extent, p70, as strong candidates for the UGPB complex. 
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8.3. What is the role of minor proteins identified by Southwestern blotting? 
Southwestern blotting also identified several minor proteins in crude progesterone-dominated 
endometrial extracts. Several of these (MW approx. 180kDa, 145kDa, 80kDa, 60kDa, 35kDa, 
28kDa and 26kDa) were sometimes detected in heparin-agarose purified progesterone-dominated 
endometrial extract. These proteins have not been investigated in detail and there are essentially 
four possibilities for their role. Firstly they may be non-specific DNA binding proteins such as 
histones or topoisomerases. Chapter 3 established that non-specific proteins able to bind VG200 are 
present in heparin-agarose purified progesterone-dominated endometrium (Plate 6). A second 
possibility is that they are low specificity DNA binding proteins not involved in VGPB. VG200 is a 
large fragment of DNA and could potentially contain binding sites for several other transcription 
factors. The fact that several minor proteins are able to bind fragments of the uteroglobin promoter 
that UGPB does not bind to is evidence for this (Plate 25) and such proteins would also explain the 
presence of minor shifts in the gel shift assay. Thirdly, they may be cleavage products or precursors 
of pl05 and/or p70. The fact that some are co-purified with p105 and p70 is evidence for this (Plates 
9 & 10), but the diversity of proteins detected suggests this explanation cannot be applicable to all 
of them. 
However, the experiments outlined previously cannot rule out the possibility that some or all of 
these proteins are involved in the UGPB complex. There are several lines of evidence suggesting 
that UGPB is a multi-protein complex. The UGPB footprint (-170/-85) is significantly larger than 
that for transcription factors such as Sp 1 which recognises a lObp motif (Kadonga & Tjian 1986). 
The difficulties in purifying UGPB indicate a complex that dissociates readily. The minor shifts 
observed in some gel-shift assays may be the result of incomplete complex formation and the 
decrease in mobility of the UGPB shift in overloaded gel shift assays may reflect protein-protein 
interactions between UGPB complexes (Plate 11). The minor proteins detected by Southwestern 
blotting may therefore be components of the UGPB complex. The often weak detection of these 
proteins is not necessarily evidence against their involvement in UGPB. As noted above, some 
components of a transcription factor complex are likely to have relatively weak affinity for the 
target site unless associated with other factors. The possibility that some of these minor proteins are 
involved in the UGPB complex cannot b~ ruled out. 
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8.4. A model for UGPB. 
The results of the experiments outlined above can be summarised into a model for the composition 
of UGPB. UGPB appears to be a multi-protein complex. p105 is almost certainly a component of 
this complex. p105 has a relatively low specificity, which explains the observations that 
contaminating DNA extracted from nuclei can interfere with UGPB-UG200 binding and the ability 
of AT rich DNA to compete the UGPB shift (P. Daniel, personal communication). Low specificity 
does not preclude proteins from being involved in transcription complexes, because it would be 
difficult for the activity of a transcription complex to be regulated if all components had a high 
specificity or affinity for the target site, as the complex would not readily dissociate (Frankel & Kim 
1991). Many transcription factors may in fact regulate several genes, so it is important that they are 
able to release easily from their binding site. p 105 appears to be present in the endometrium 
regardless of hormone status, along with lung and ovary extracts. By contrast uteroglobin is strictly 
regulated by hormones in the endometrium and lung. Although p105 may playa role in the 
regulation of uteroglobin expression, its presence in conditions wherein uteroglobin is not expressed 
suggests it may be a general transcription factor in these tissues. 
p70 may also be involved in UGPB, although further analysis of affinity purified samples is 
necessary to verify this. p70 binds UG200 more specifically than p105 and may therefore playa role 
in stabilising p 105 interaction with UG200. The fact that when p70 is not present (in affinity 
purified extract, ego Plate 12) or is unable to bind the probe (when using the -170/-100 region as a 
probe, C. Molloy, personal communication), the intensity of the UGPB shift is reduced suggests that 
p70 binding is not essential for UGPB formation, but may stabilise the UGPB complex. Like p105, 
p70 does not appear to be specific to progesterone-dominated endometrium, so may playa role 
outside the regulation of uteroglobin expression. 
Finally, there is the possibility that other minor proteins detected by Southwestern blotting may also 
be involved in the UGPB complex in a direct DNA-binding role or by regulating protein-protein 
interactions. Because some transcription factors act via an "induced fit" mechanism, whereby the 
structure of the DNA-binding domain is regulated by interaction with other components of the 
transcription factor complex, accessory proteins could determine the overall specificity of the 
transcription complex. As the presnce of p 1 05 and p70 is not confined to progesterone-dominated 
endometrium, it may be that expression of accessory proteins regulates the specificity of the 
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P 105/p70 complex and therefore it is these components of the UGPB complex that are linked to 
progesterone treatment. 
8.5. Future Directions. 
Purification of UGPB is the most important approach to identify a role for the proteins identified by 
Southwestern blotting, although other approaches are also available. One possibility is to attempt to 
reconstitute the UGPB complex after the electroblot transfer stage of Southwestern blotting, by 
incubating the membrane with crude nuclear extract before blocking. This may allow identification 
of minor proteins that have low affinity for UG200 unless they are part of the UGPB complex. 
Electroelution of UGPB from the gel shift assay is also a fundamental step, to relate proteins 
identified by purification to those that cause the UGPB shift. Finally UV cross linking could be used 
to determine the molecular weight of the UGPB complex and so indicate whether p105 alone forms 
the UGPB complex or whether additional proteins such as p70 are involved. Once the composition 
of UGPB has been delineated, the role of its components in the regulation of endometrial 
uteroglobin expression can be analysed by the use of an in vitro transcription system. 
Southwestern blotting has identified two candidate proteins for UGPB, which have different target 
DNA sequences and specificities. It has also highlighted the fact that UGPB may well be a complex 
of several proteins of differing specificity and affinity, some of which are not restricted to 
progesterone-dominated endometrium and therefore are not solely involved in the regulation of 
uteroglobin expression. 
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APPENDICES 
Appendix 1 • Separation of proteins by 
SDS·Polyacrylamide Gel Electrophoresis. 
1) Proteins samples at equal salt concentrations were incubated with one volume of 2* 
sample buffer [5% (w/v) SDS; 5mM Tris Hel (pH 6.8); 200mM DTT; 20% (v/v) 
glycerol; 50mM NaCl; 0.05% (w/v) bromophenol blue] for 30 minutes at room 
temperature (approx. 20 0 e). 
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2) Samples were run on 10% resolving gel (37.5:1 acrylamide:bisacrylamide in [375mM 
Tris Hel (pH 6.8); 2mM EDTA; 0.1% (w/v) SDS]) with 0.5mm 5% stacking gel (37.5:1 
acrylamide:bisacrylamide in [125mM Tris Hel (pH 8.8); 2mM EDTA; 0.1 % (w/v) SDS]) 
at 200V (approx. 30mA and 7W) until bromophenol blue emerged from end of resolving 
gel. Gel sizes: Mini-Protean II 6cm * 8.3cm; Protean II 13.4cm * 16.2 cm. 
3) Electrophoresis was conducted at room temperature (approx. 20 0 C) with upper 
chamber buffer composition [125mM Tris; 960mM glycine; 0.5% (w/v) SDS] and lower 
chamber buffer [25mM Tris]. 
Appendix 2 • Electroblot transfer 
(Horizontal electophoretic transfer of proteins. 
1) A piece of Immobilon-P membrane was cut to the same size as the resolving gel and 
soaked in methanol for 5 minutes to activate. Immobilon-P was always handled with 
gloves. 
2) Activated membrane was soaked in transfer buffer [25mM Tris; 192mM glycine; 20% 
(v/v) methanol; 0.05% SDS] along with 4 pieces of 3M filter paper cut slightly smaller 
than the resolving gel. The membrane and filter paper remained soaking in transfer buffer 
for at least 10 minutes. 
3) After separation of proteins by electrophoresis (see Appendix 1), the small glass plate 
was removed from the gel. If the membrane was to be separated after transfer, pieces of 
gel between lanes to be separated were removed with a Pasteur pipette. 
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4) The orientation of the gel was marked by removing a fragment at the upper left hand 
comer, the stacking gel was removed and the resolving gel was equilibrated in transfer 
buffer for 10 minutes. 
5) The gel was placed on a large glass plate and two sheets of pre-soaked filter paper 
were laid on it, rolling gently with glass rod to exclude any bubbles. Care was taken to 
ensure that the filter paper did not protrude past the edge of the gel to avoid current 
bypass during electrophoresis. 
6) The gel and filter paper were transferred from the glass plate and laid on a Scotch-brite 
porous pad, with gel uppermost. The pre-soaked Immobilon-P membrane was laid on gel, 
ensuring the top of the membrane is aligned exactly with the top of the gel and rolling 
with a glass rod to exclude bubbles. 
7) Two pre-soaked pieces of filter paper were placed onto the membrane, again rolling to 
exclude bubbles and ensuring the filter paper does not protrude past the membrane. 
8) A Scotch-brite porous pad was placed on top of the assembly, and the assembly was 
secured in a cartridge. 
9) The cartridge was placed vertically in an electrophoresis chamber, ensuring the 
membrane was closest to the positive electrode. 
10) Electrophoresis was carried out for 16-24 hours at 250mA (approx. 20V and lOW) at 
4°C. 
11) After transfer, membrane was sometimes kept in a plastic bag at 4 ° C for up to 4 days 
before use. 
Appendix 3 - Amido Black staining of 
membrane bound proteins. 
1) After electroblotting, the cartridge was opened and filter paper removed. 
2) The position of the marker lane and lanes to be cut was marked on the membrane with 
pencil, by observing the position of the regions of gel excised between lanes in step 3, 
Appendix 2. 
3) The marker lane was removed from the remainder of the membrane and incubated in 
Amido Black Stain solution [25% (v/v) isopropanol; 10% (v/v) acetic acid; 0.1 % (w/v) 
amido black] for 5 minutes at room temperature (approx. 20 ° C). 
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4) Membrane was destained in two changes of 25% (v/v) isopropanol; 10% (v/v) acetic 
acid and air dried. 
Appendix" - Southwestern Blotting. 
1) The membrane was placed in a plastic bag (cut to be just larger than the membrane) 
with blocking buffer [lOmM Hepes (pH 8.0); 5% (w/v) non-fat dry milk]. Volume of 
blocking buffer, binding buffer and double end labelled UG200 used varied with size of 
membrane (see Methods in text). 
2) Bubbles were removed from the bag, which was heat sealed and incubated for 1 hour 
at room temperature (approx. 200 e) with a weight on bag to ensure even distribution of 
blocking buffer over the membrane. 
3) The membrane was transferred to another plastic bag containing binding buffer [10mM 
Hepes (pH 8.0); 50mM Nael; lOmM Mgel2; O.lmM EDTA; 1mM DTT; 0.25% non-fat 
dry milk]. 
4) Bubbles were removed and the bag was heat sealed. 
5) Double end labelled UG200 in O.5mL binding buffer was injected at one corner of the 
sealed bag and the injection site was heat sealed after injection. 
6) The liquid was rolled around the plastic bag with glass rod to ensure even distribution 
of probe and incubated for 1 hour at room temperature (approx. 20° e) with weight on 
bag. 
7) The membrane was removed and washed twice in 50mL wash buffer [20mM Tris Hel 
(pH 7.5); 40mM Kel; ImM MGeL2; ImM EDTA; 1mM DTT] for 10 minutes at room 
temperature (approx. 20 ° e). 
8) The membrane was air dried and exposed to Kodak X -Omat AR film for 1-14 days at 
-100°e. 
9) Before developing film, the film cassette was left at room temperature (approx. 20 ° e) 
for 1 hour to defrost. 
Appendix 5 - Denaturation/Renaturation of 
membrane bound proteins. 
98 
1) After electroblotting, the membrane was placed in a plastic bag (cut to be just larger 
than the membrane) with blocking buffer [lOmM Hepes (pH 8.0); 5% (w/v) non-fat dry 
milk]. Volume of blocking buffer used varies with size of membrane (see Methods in 
text). 
2) Bubbles were removed and the bag was heat sealed. The membrane was incubated for 
1 hour at room temperature (approx. 20 0 C) with a weight on bag to ensure even 
distribution of Blocking Buffer over the membrane. 
3) The membrane was removed and washed twice in SOmL TGEM 100/2 [20mM Tris 
HCI (pH 7.S; lS% (v/v) glycerol; 1mM EDTA; 5mM MgCI2; 5mM DTT] for 5 minutes. 
4) The membrane was soaked in 50mL denaturation buffer [7M Guanidine HCI; 50mM 
Tris HCI (pH 8.0); SOmM DIT; 2mM EDTA; 0.2S% non-fat dry milk], shaking at 4 0 C 
for 1 hour. 
5) The membrane was transferred to SOmL renaturation buffer [50mM Tris HCI (pH 8.0); 
100mM NaCI; 2mM DIT; 2mM EDTA; 0.1 % Nonidet P-40; 0.2S% non-fat dry milk], 
and shaken at 4 0 C for 20 hours. 
6) The membrane was removed and subjected to Southwestern blotting as in Appendix 3. 
Appendix 6 - Isolation of nuclear proteins 
from rabbit tissue samples. 
a) Purification of nuclei. 
1) Tissues were removed after sodium pentabarbitone anesthesia and rinsed in ice-cold 
0.9% (w/v) NaCl. 
2) All buffers had 1 ttL/lmL Protease Inhibitor Cocktail I [lmg/mL leupeptin; 2mg/mL 
antipain; lOmg/mL Benzamidine], 2SttL/lOmL Protease Inhibitor Cocktail II [1mg/mL 
Chymostatin; 1 mg/mL Pepstatin A] added and were made ImM DIT and 2mM 
phenylmethylsulfonylfluoride (PMSF) immediately before use. All buffers were stored 
on ice and all steps in the isolation procedure were carried out on ice. 
99 
3) Uterine horns were opened longitudinally, the surface scraped with a scalpel and these 
endometrial scrapings used in the following procedure. All other tissues were minced 
before nuclei extraction .. 
4) Tissues were homogenised in 5 volumes of homogenisation buffer [0.3M sucrose; 
10mM Tris HCI (pH 7.5); 3mM magnesium acetate] by five passes of a teflon pestle in a 
glass homogeniser. 
5) Lysed cells were centrifuged in a Sorvall SS-34 rotor at 1500g for 10 minutes at 4 0 C. 
5) Pellets were resuspended in 5 volumes of homogenisation buffer containing 0.1 % 
Triton X-l00 by two passes of a teflon pestle in a glass homogeniser. 
6) Samples were passed through four layers of cheese cloth. 
7) Filtrate was centrifuged in a Sorvall SS-34 rotor at 1500g for 10 minutes at 4 0 C. 
8) Pellets were resuspended in 4 volumes of homogenisation buffer made 1.5M sucrose 
by two passes of a teflon pestle in a glass homogeniser. 
9) Samples were layered on a 1 volume homogenisation buffer made 1.5M sucrose 
cushion and centrifuged in an Sorvall SS-34 rotor at 20 OOOg for 90 minutes at 4 0 C. 
10) Pellet (nuclei) was resuspended in 5 volumes of nuclear buffer [25% (v/v) glycerol; 
50mM Tris HCI (pH 7.5); 5mM Magnesium Acetate; 5mM DTT; O.lmM EDTA], and 
stored at 
-100 0 C. Samples were set aside to estimate the DNA content by diphenylamine assay 
(see Appendix 9). 
b) Extraction of proteins from nuclei. 
1) Frozen nuclei were thawed on ice and centrifuged in a Sorvall SS-34 rotor at l000g for 
10 minutes at 4 0 C. 
2) Pellets were resuspended in nuclear extract buffer [O.4M KCI; 20mM Tris HCI (pH 
7.85); 0.25M sucrose; 1.1 mM MgCI2; 10mM 2-mercaptoethanol] by stirring with glass 
rod. Volume of nuclear extract buffer used was determined by the estimated DNA content 
of the samples, with 20mL nuclear extract buffer used for every l00mg DNA. 
3) Proteins were extracted on ice for 10 minutes, and centrifuged in a Sorvall SS-34 rotor 
at 1500g for 10 minutes at 4 0 C. 
4) The supernatant was removed and made 15% (v/v) glycerol. 
5) Nuclear proteins were stored at -100 0 C. Samples were set aside to estimate the protein 
concentration by Bradfords assay (see Appendix ?). 
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Appendix 7 - Double end labelling of UG200. 
1) 100ng UG200, 2t,LL buffer and nucleotide mix (Amersham Megaprime DNA labelling 
system) and 0.3 t,LL Klenow (??U) were incubated with 2.5 t,LL (25 t,LCi) [a_32p dCTP] in a 
1.5mL Eppendorf tube at room temperature (approx. 20 0 C) for 1 hour. 
2) DNA was precipitated by addition of 4.5t,LL 9.5M NH4 acetate and 30t,LL ice cold 
100% ethanol and incubated at 
_20 0 C for 20 minutes. 
3) Sample was centrifuged for 10 minutes, and the supernatant was removed and 
discarded. 
4) The pelleted DNA was washed twice with 100t,LL 70% ethanol, centrifuging and 
removing the supernatant after each step. 
5) The pellet was air dried and resuspended in 166t,LL TE [20mM Tris HCI (pH 7.5); 
ImM EDT A], resulting in a concentration of 0.6ng/ t,LL. 
6) The resulting UG200 is labelled as follows: 
* 
5' TGCA ------------------------CT AG 3' 
3' AGCT------------------------GATC 5' 
* 
Appendix 8 - Gel-shift assay for DNA binding proteins. 
1) A 4% polyacrylamide gel [80:1 acrylamide:bisacrylamide in 0.5* TBE [45mM Tris-
borate; ImM EDTA]) was pre-electrophoresed at 240V for at least one hour. Gel size: 
13cm * 17cm. 
2) Nuclear proteins were made to equal salt concentrations (lOOmM to 340mM - see text) 
and incubated with 0.6ng double end labelled UG200 and 4t,Lg dldC in a total volume of 
20tLL at 15 0 C for 30 minutes. 
3) Samples were mixed with 2tLL loading buffer [50% (v/v) glycerol; 0.05% (w/v) 
bromophenol blue] and loaded on to the pre-electrophoresed 4% polyacrylamide gel. 
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4) Electrophoresis is carried out with 0.5* TBE at 240V for approx. 90 minutes at 15 0 C. 
5) The gel is transferred to a piece of filter paper and dried on a Hoefer Scientific 
Instruments Grygel Sr. Slab Gel Dryer .. 
6) Died gel is exposed to Kodak X -Omat AR film for 1-7 days at -100 0 C. 
Appendix 9 - Diphenylamine assay for DNA concentration. 
1) DNA samples were made up O.5mL with distilled H20, mixed with O.5mL 100M 
perchloric acid in 13mm * 100mm Kimble tubes and left on ice for 1 hour. 
2) Samples were centrifuged at 4000g for 5 minutes and the supernatant, containing acid 
soluble nuc1eotides, was discarded. 
3) The pellet was resuspended in 1.0mL 0.5M perchloric acid. 
4) Standards were made up to 1.0mL with 0.5M perchloric acid. 
5) Samples and standards were incubated at 90 0 C for 30 minutes and shaken twice 
during the incubation. 
6) Samples and standards were centrifuged at 4000g for 5 minutes, and the supernatant 
was transferred to clean 13mm * 100mm Kimble tubes. 
7) 1mL solution C (20mL diphenylamine reagent [87mM diphenylamine; 1.5% (v/v) 
H2S04 (conc.); in glacial acetic acid] mixed with O.lmL 1.6% acetaldehyde) was added 
to each tube and all tubes were incubated overnight in the dark at room temperature 
(approx. 20 0 C). 
8) A600 of samples and standards was measured. 
Appendix 10 - Purification of DNA fragments by 
electrophoresis onto DEAE-cellulose membrane. 
1) Polyacrylamide gel fragments containing DNA were placed onto a 0.1 % agarose gel 
and covered with a further layer of 0.1 % agarose. 
2) An incision was made in the agarose gel directly in front of each embedded 
polyacrylamide gel fragment. 
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3) Using gloves, a piece of Schleicher & Schuell NA-45 DEAE-cellulose membrane was 
cut the same width and slightly deeper than the incision. 
4) The membrane was activated by soaking for 5 minutes in lOmM EDTA (pH 8.0), then 
soaking in O.5N NaOH for 5 minutes and finally washing six times with sterile H20. 
5) Activated membrane was inserted into each incision. 
6) 2J,LL loading dye [4M urea; 50% (w/v) sucrose; 0.1 % (w/v) bromophenol blue; 0.1 % 
(w/v) xylene cyanate; 0.25M EDTA] was stabbed into the gel directly behind the 
polyacrylamide gel fragment to estimate the distance the DNA had travelled. 
7) Electrophoresis at 120V was carried out until the xylene cyanate band from the loading 
dye was trapped on the membrane (approx. 60 minutes). 
8) Membranes were removed, washed briefly in low salt wash buffer [50mM Tris HCI 
(pH 8.0); O.ISM NaCI; lOmM EDTA] and transferred to a 1.5mL Eppendorftube 
containing 100J,LL high salt elution buffer [50mM Tris HCI (pH 8.0); 1M NaCI; lOmM 
EDTA]. 
9) Membranes were incubated with high salt elution buffer for 30 minutes at 65 0 C, 
supernatant removed and extraction repeated with another lOOJ,LL high salt elution buffer. 
10) Supernatants were combined and mixed with 30J,LL phenol and 30J,LL 24:1 isoamyl 
alcohol:chloroform to remove proteins. 
11) Tubes were centrifuged for 10 minutes, aqueous layer removed and mixed with 60J,LL 
24: 1 isoamyl alcohol:chloroform to remove phenol. 
12) Tubes were centrifuged for 10 minutes, aqueous layer removed and incubated with 
50 J,LL 9.5M NH4 acetate and 500 J,LL ice cold 100% ethanol at -20 0 C overnight to 
precipitate the DNA. 
13) Tubes were centrifuged, supernatant removed and pellet washed twice with 100 J,LL 
70% ethanol, centrifuging and removing the supernatant after each wash. 
14) The pellet was air dried and resuspended in 30J,LL TE [20mM Tris HCI (pH 7.5); 
ImM EDTA] for use in Southwestern blotting and gel shift assays. 
Appendix 11 - Silver staining for proteins 
in an SDS Polyacrylamide gel. 
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1) Gel was fixed in 25% (v/v) isopropanoVlO% (v/v) acetic acid for 120 minutes at room 
temperature (approx. 20 0 C), changing the solution every 30 minutes. 
2) Gel was washed twice in distilled H20, and soaked in a third change of distilled H20 
overnight (approx. 16 hours). 
3) Gel was soaked in 0.0325M DTI for 30 minutes and rinsed in distilled H20. 
4) Gel was soaked in 0.1 % AgN03 for 120 minutes and rinsed rapidly in three changes 
distilled H20. 
5) Gel was transferred to 200mL developer solution [0.0185% (v/v) formaldehyde; 3% 
(w/v) Na2C03]. 
6) When staining had reached desired intensity, developing reaction was stopped by 
adding lOmL 2.3M citric acid and soaking for 10 minutes. 
7) The gel was washed with several changes of distilled H20 for 30 minutes. 
8) Gel was soaked in 5% (v/v) glycerol for 2 minutes, transferred to 3M filter paper and 
dried in a gel dryer?? 
Appendix 12 - Elution of proteins from 
gel shift assay gel. 
1) Gel shift assay carried out as in Appendix 8, but with several reaction mixes omitting 
double end labelled UG200 to act as a negative control. 
2) The gel was not dried, and exposed to Kodak-AR X-Om at AR film overnight at 
_100 0 C. 
3) The position of the shift on the gel was marked by comparison with developed 
autoradiograph. 
4) The gel at the shift site was excised and placed in 15mL Elution Buffer [lOmM Tris 
(pH 8.0); ImM EDTA; 0.1% SDS]. 
5) A region of gel the same distance from the origin as the shift was excised from the 
negative control lanes, and placed in 15mL Elution Buffer. 
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6) The gel was re-exposed to Kodak X-Gmat AR film overnight to confirm excision of 
the shift. 
7) Both samples were shaken overnight at 37 0 C. 
8) Gel fragments were removed by filtration, and the eluate was vacuum concentrated to 
approximately 1mL in a Savant SpeedVac Concentrator. 
9) Eluates were then mixed with 4 volumes acetone to precipitate proteins. 
10) The supernatant was removed and the precipitate resuspended in 25~ SDS-PAGE 
sample buffer as in Appendix 1. 
